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Gold nanoparticles (AuNPs) have attracted enormous attention in the field of 
nanotechnology for applications such as, immunoassay, drug delivery, contrast 
enhancement and tumor therapy. The typical range of gold nanoparticles varies from 1–
150 nm; there are many different subtypes of AuNPs mainly based on size, shape, and 
optical properties including: gold nanospheres, nanorods, nanocages, and nanoshells. The 
main advantage of using gold nanoparticles is the large surface-to-volume ratio; this will 
allow the particles to be functionalized with drugs and/or targeting agents to create many 
novel applications.  Many AuNPs have another advantage as well, they can be fabricated 
to either absorb or scatter light in the visible to near-infrared (nIR) region of the 
spectrum. Current research, using gold nanoparticles, mainly focuses on taking advantage 
of the nIR window. In biomedical research the nIR window is very important; nIR light 
has minimal interference with tissue and only affects samples which absorb nIR light, 
which enables minimally invasive imaging and treatment.  
Specifically, gold/gold sulfide nanoparticles (GGS) have been introduced for 
many applications compared to silica-gold nanoshells due to the smaller size of particles. 
This project is focused on a novel purification/high yield process of GGS nanoparticles 
using chloroauric acid (HAuCl4) and sodium thiosulfate (Na2S2O3), with desired nIR 
peak that can be used for therapeutic applications. By combining the traditional published 
methods for 1-step self-assembly of GGS nanoparticles and dialysis techniques 
simultaneously, a new method for production of gold / gold-sulfide nanoparticles has 
been established in this research project which we call DiaSynth. In this process the 
equilibrium of the reaction is shifted to favor the formation of nIR absorbing particles. 
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This technique minimizes production of gold nanoparticles with 530 nm resonance 
(colloidal gold), resulting in populations of nanoparticles that require minimum further 
processing for use as a therapeutic agent. The colloidal gold is considered a contaminant, 
formed during the self-assembly process, which are traditionally removed via multi-step 
centrifugation. We define a ratio of the absorbance of peaks, RnIR/Au ; this is based on the 
peak absorbance in of the nIR region (700 – 900 nm) relative to the colloidal gold peak 
(~530 nm) as a relative measure of the quality of nIR particles. The current method for 
producing nIR GGS, based on a single step procedure, results in a poor ratio, RnIR/Au = 
0.7 – 1.0. The DiaSynth method utilizes a shift in kinetics via removal of smaller ions and 
other products during the reduction of gold and sulfur. This method has allowed us to 
increase the yield of as made product to have an RnIR/Au = 1.7 – 2.0. In comparison, 
purification by centrifugation results in great loss of particles during each step to achieve 
similar ratios. At a ratio of 1.7 – 2.36, no centrifugation is needed to separate out 
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CHAPTER 1 – Gold Nanoparticles 
1.1 INTRODUCTION  
Gold nanoparticles 
Biomedicine, involving the study of processes in biology, chemistry, and physics, 
has been one of the cores in nanotechnology (W. Cai 2008). Gold nanoparticles vary in 
size, typically in the range of 1–150 nm (Azzazy and Mansour 2009). However, there are 
many different subtypes of AuNPs based on their size, shape, and properties including: 
gold nanospheres, nanorods, nanocages, and nanoshells (W. Cai 2008). One important 
property of these nanoparticles is a large surface-to-volume ratio, though most of the 
nanoparticles have the size range of biomolecules and cellular organelles; not only does 
this give a possibility of interaction between the gold nanoparticles and biomolecules, but 
opens the field to various medical applications (Azzazy and Mansour 2009).  
Nanoparticles can specifically be tuned as nano-platforms for an effective and 
targeted delivery of drugs, and imaging labels by reducing  many biological, biophysical, 
and biomedical limitations for many application in vitro and ex vivo (W. Cai 2008). Due 
to the versatile properties gold nanoparticles (AuNPs), they have been introduced in the 
field of biomedical applications for drug delivery, ex/in-vivo imaging, in-vitro assays, 
and cancer therapy (theranostic applications) (W. Cai 2008). For many biological 
applications, gold nanoparticles must be conjugated with assorted biospecific recognition 
molecules, including antibodies, DNA probe molecules, biotin, and enzymes (Azzazy and 
Mansour 2009; Xie, Gao et al. 2009). By using different stabilizing molecules/agents 
gold nanoparticle properties can be altered. These biospecific molecules can be replaced 
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by other macromolecules; not only can the surface of gold nanoparticles be modified 
either by coating or by grafting a macromolecule, but the properties of nanoparticles can 
be changed such as adsorption, size, zeta potential (charge), and hydrophobicity 
(Agbenyega 2008; Rai 2011). 
Most of these applications are based on the advantage of using the unique optical 
properties of gold, such as surface plasmon resonance (SPR), luminescence, surface-
enhanced Raman scattering, catalytic effect, and amplification effect (Azzazy and 
Mansour 2009; Xie, Gao et al. 2009). In order to attach or coat the surface of gold 
nanoparticles with biospecific molecules, they are usually connected with ligands. 
Alkanethiols are the most common self-assembled monolayer (SAMs) used for 
passivating gold nanoparticles (Huo 2007; Rai 2011). Gold nanoparticles have been used 
as contrast agent for scanning electron and light microscopy in histology; they also have 
played an important role in advancing biosensor performance due to their large effective 
surface area and excellent biocompatibility (Huo 2007; Rai 2011).  
AuNPs has been used in stained glass windows for centuries. However, recently, 
in the last decade or so, researchers have begun to understand the fundamental concepts 
that not only explain the optical properties at the nanoscale, but how these particles can 
be used in many different applications (Stone, Jackson et al. 2011). AuNPs can be 
fabricated to either absorb or scatter light in the visible to near-infrared (nIR) region of 
the spectrum (Lowery, Gobin et al. 2006; Gobin, Lee et al. 2007; Day, Bickford et al. 
2010; Gobin, Watkins et al. 2010; Stone, Jackson et al. 2011). These unique optical 
properties are a result from the oscillations of electrons along the metal surface, which 
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can be changed by modifying the particles’ shape, size, or the medium that particles are 
suspended in (Pérez-Juste, Pastoriza-Santos et al. 2005; Stone, Jackson et al. 2011).  
1.2 Applications 
Theranostic applications have emerged as a technique to combine diagnosis, 
treatment, and imaging in cancer research, thus not only decreasing time, but improving 
efficacy of therapy. The ideal theranostic approach for cancer therapy has several tunable 
factors, which can range from imaging to treatment with a display of specifically 
targeting cancer cells (Young, Figueroa et al. 2012). Researchers have now begun to 
introduce multimodal nanoparticles for therapeutic and imaging contrast applications 
(Ren and Chow 2003; Park, Yang et al. 2008; Jelveh and Chithrani 2011; Sun, Eun et al. 
2011). Specifically, gold/gold sulfide nanoparticles (GGS) has been developed for many 
of the same applications compared to silica-gold nanoshells because of the smaller size, 
higher absorptive properties, and easier to fabricate using the single-step self-assembly 
process described in the later parts of the chapter. (Gobin, Watkins et al. 2010). The 
theranostic effects of GGS are the result of surface plasmon oscillations to convert light 
into heat, causing increase in local temperature to ablate the specifically targeted cells, 
which occurs using frequency of light that matches the absorptive properties of GGS 
(Vladimir P. Zharov 2003; Song, Risco et al. 2008; Ghosh, Dutta et al. 2009; Lapotko 






1.2.1 Nanoshells  
Gold nanoshells (GNS) are tunable spherical nanoparticles, composed of a 
dielectric core covered by a thin gold shell, with diameters ranging from 10 to 200 nm 
(Erickson and Tunnell 2007). (Figure1) GNS have optical, chemical and physical 
properties, which make them an ideal candidate for enhancing cancer detection, cancer 
treatment, cellular imaging, and medical biosensing. Furthermore, gold affinity for thiol 
group with biocompatibility and it also simplifies conjugation to monoclonal antibodies 
or other biomolecules for both active tumor targeting and biosensing applications. 
Nanoshells can be fabricated with tunable optical properties, absorbing or scattering, 
from visible to infrared spectrum.  











Figure 1:  Spectral profile (A) image of the GNS that were fabricated with radius 
of ~74 nm and core of ~60 nm and STEM image (B) to confirm the synthesis. 
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GNS, due to their unique physical characteristics and benign toxicity profile, have 
been using in number of biomedical applications (Erickson and Tunnell 2007); however, 
they have shown the greatest potential for cancer targeting, imaging, and therapy agents.  
The use of GNS in contrast agents has been utilized to detect and image individual cancer 
cells in vitro and in vivo (Lowery, Gobin et al. 2006; Erickson and Tunnell 2007; Gobin, 
Lee et al. 2007). As a photothermal agent, GNS have successfully shown, in animal 
studies, to induce thermal necrosis of tumors. As biosensors, GNS have been used for the 
sensitive detection of biomarkers at the ng/ml concentrations (Hirsch, Jackson et al. 2003; 
Erickson and Tunnell 2007).    
1.2.2 Nanorods 
 
AuNPs having a “rod-like” structure has been in interest due to their unique 
shape. The spectral profile of the gold nanorods includes two specific bands: one due to 
light absorbed along the short axis (~530 nm) and the other due to absorption along the 
long axis (~650-1000 nm) (Stone, Jackson et al. 2011). As the length of the nanorod 
increases, there is a red band shift, and because of this optical “control gold nanorods can 
be used for sensing, photothermal therapy, and imaging (Pérez-Juste, Pastoriza-Santos et 
al. 2005; Stone, Jackson et al. 2011). 
   The correlation between gold nanorod size, charge, shape, and spectral profile as 
a result of changes in dielectric and interparticle spacing, makes them acceptable as 
sensors (Yu and Irudayaraj 2006; Stone, Jackson et al. 2011). Yu and Irudayaraj et al. 
demonstrated a multiplex sensing system using gold nanorods with three different 
targeted IgGs. Yu and Irudayaraj et al. were able to measure the specificity and 
sensitivity caused by interactions between the IgGs and gold nanorods (Yu and Irudayaraj 
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2006). This approach can be used in the development of optical biosensors for both in 
vivo and in vitro detection. However, Huang et al. demonstrated the potential usage of 
gold nanorods as a dual agent, molecular imaging and photothermal ablation therapy of 
cancer cells using a near-infrared laser. Hunag et al, conjugated anti-epidermal growth 
factor receptor (anti-EGFR) antibodies to the surface of gold nanorods to be used as for 
targeting (Huang, El-Sayed et al. 2006).  
1.2.3 Nanocages 
Gold nanocages represent a class of gold nanostructures with hollow interiors and 
porous walls (Chen, McLellan et al. 2006; Yavuz, Cheng et al. 2009). Gold nanocages 
has a strong absorption in the near-infrared region (Yavuz, Cheng et al. 2009). As 
mentioned by Yauvz et al., when the surface of a gold nanocage is covered with a  
“smart polymer”, using a near-infrared laser to heat the polymer or the surface of the 
nanocage allows the release of a drug. Xai et al. functionalized the surface of gold 
nanocages with thermally responsive polymer, poly(Nisopropylacrylamide) (pNIPAAm) 
with a gold thiolate bonding, to control the release of a drug using near-infrared laser 
irradiation (Xia, Li et al. 2011).  The pNIPAAm polymer chain has the ability to change 
conformation in response to temperature variation, and can be modified using different 
amounts of acrylamide. Once the gold nanocages undergo laser irradiation, the light is 
absorbed and converted into heat. Next, the polymer chains will collapse as the 
temperature increase, which ultimately leads to the opening of pores and thus releasing 
the drugs (Yavuz, Cheng et al. 2009; Xia, Li et al. 2011).  
Chen et al. evaluated the use of PEGylated Au nanocages with passive targeting 
capabilities in a tumor mouse model (Chen, McLellan et al. 2006). The passive targeting 
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depends on the aggregation of the nanoparticles in a tumor through leaky vasculature. 
However, active targeting, the second type of targeting system, takes advantage of the 
interaction between the ligand/IgG (targeting agent) immobilized on the surface of 
nanoparticles and the specific receptor, which is being targeted, overexpressed on the 
surface of tumor cells. It was observed that due to the enhanced permeability and 
retention effect, the nanocages had an increased circulation time, which meant that they 
could accumulate in the tumor site (Chen, McLellan et al. 2006).  
1.2.4 Nanospheres 
Chemotherapy, for different types of cancer treatment, can produce harmful side 
effects since it involves saturating the body with toxic drugs (Shah and Schwartz 2001). 
Using a unique drug delivery system offers advantages such as improved efficacy and 
reduced toxicity. Improvement in chemotherapy can be achieved through passive or 
active targeting  using gold nanospheres (Kim, Ghosh et al. 2009). There are two 
different types of gold nanospheres (colloidal gold) separated by the fabrication methods, 
sodium citrate reduction and sulfur reduction. Both methods produce nanoparticles of 
different resonant properties (Brown, Nativo et al. 2010; Day, Bickford et al. 2010; 
Gobin, Watkins et al. 2010).  
Kim et al had described using gold nanoparticles as multimodal drug delivery 
systems. Using the fabrication process to control the size of gold nanoparticles, which 
ultimately gives its high surface area to volume ratio, the gold nanoparticles can be 
loaded with multifunctional monolayers, which allows multiple functional moieties such 
as drugs and targeting agents to be functionalized on the surface (Kim, Ghosh et al. 
2009).   
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Day and Gobin et al developed a near-infrared resonant gold-gold sulfide 
nanoparticle system, not only as contrast agent, but therapeutic agents for breast cancer 
treatment using photoablation (Day, Bickford et al. 2010; Gobin, Watkins et al. 2010). 
The gold nanoparticles were functionalized with a conjugated anti-HER2 antibodies, this 
will allow the nanoparticles to specifically bind breast carcinoma cells which overexpress 
the HER2 receptor. Both reported that gold / gold-sulfide nanoparticles are a suitable 
material for multifunctional agent for cancer treatment.  
1.3 Synthesis & Theory  
 
GGS nanoparticles are synthesized by reacting sodium sulfide (Na2S) or sodium 
thiosulfate (Na2S2O3) with chloroauric acid (HAuCl4), using the traditional single step 
method or a two-step method; although, according to published papers, this synthesis is 
surrounded by the issues over structure formation of the resulting product and other 
byproducts formed during the self-assembly process (Schwartzberg, Grant et al. 2007). 
The traditional one-step GGS reaction is carried out by mixing 2 mM solution of HAuCl4 
with 1 mM Na2S solution (after it has been aged), with a volumetric ratio of 1:2, while 
stirring at room temperature (RT) (Diao and Chen 2006). However, the two-step 
synthesis, discovered by Zhou et al (Figure 1), requires the HAuCl4 and Na2S solutions to 
react for few minutes (first reduction) and then a second reduction, Na2S solution, is 
added to formulate the metal-coatings on the nanoparticles (Zhou, Honma et al. 1994). 
Both self-assembly processes will result in formation of variety of particles: colloidal 
gold, GGS (circular/spherical), triangular plates, and rods (Diao and Chen 2006; 
Schwartzberg, Grant et al. 2007; Gobin, Watkins et al. 2010).          




Figure 2: Spectral profiles of gold nanoparticles during the 
two-step synthesis. A, B, and C are different parameters that 
were used by Zhou et al for further understand the two-step 
self-assembly process (Zhou, Honma et al. 1994).  
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The spectral profile of the synthesized particles contains a plasmon resonance band at 
wavelengths of 520–540 nm (colloidal gold) and a near infrared peak (nIR) peak between 
650–1000 nm (GGS, triangular plates, and rods) (Zhou, Honma et al. 1994; Averitt, 
Sarkar et al. 1997; Schwartzberg, Grant et al. 2007); however, positioning of the nIR 
peak can be changed by varying the synthesis conditions  (Zhou, Honma et al. 1994; Diao 
and Chen 2006; Likhatskii and Mikhlin 2007; Schwartzberg, Grant et al. 2007; Gobin, 
Watkins et al. 2010).  For the two-step method (Figure 1), the absorbance properties are 
strictly depended on the size of the initial particle growth before the second reduction 
step is continued (Zhou, Honma et al. 1994); also this would require more time and be 
difficult (Oldenburg, Averitt et al. 1998; Prodan, Nordlander et al. 2003), specifically 
during the timing for the second reduction step to make the gold nanoparticles for optimal 
tuning , compared to the one-step method. Two theories have been formulated to 
determine the nIR peak, surface plasmon resonance of Au2S/Au nanoshells and GGS 
aggregates (Zhou, Honma et al. 1994; Averitt, Sarkar et al. 1997; Diao and Chen 2001; 
Diao and Chen 2006). Although it is hard to determine the full mechanism of the 
nanoparticle growth, researchers have developed theories, equation (1) - unbalanced, on 
the synthesis (Raschke, Brogl et al. 2004; Diao and Chen 2006; Schwartzberg, Grant et 
al. 2007; Majimel, Bacinello et al. 2008). Schwartzberg et al. has reported formation 
dithionate, S2O62-, due to oxidation of Na2S, and SO42- or SO32- species as well.  
The current synthesis requires Na2S to be aged for 2-3 days, and depending on 
how much of Na2S has been added, concentration or further aging of sample, it could 
potentially change the nIR peak. Upon further understanding the reaction of Na2S aging, 
Schwartzberg et al determined two things: (1) due to a chemical change during aging 
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process of Na2S solution there was an increase in nIR absorption, and (2) that Na2S2O3 is 
the likely product from Na2S aging because of oxygen exposure to form sulfur oxide 
species. It was also reported that Na2S2O3 solution is more stable than Na2S solution, and 
aging had no effect on the synthesis of the particles compared to Na2S aging. Although, 
with the usage of Na2S2O3, it still produces same results (colloidal gold, GGS, triangular 
plates, and rods), it is not known whether the same “species” are being formed or not 
(Schwartzberg, Grant et al. 2007). 
1.3.1 Models of Growth and Resonant Properties  
Over the last few decades, the development of optically controllable 
nanostructures came from Zhou et al. and later by Averitt et al., which reported 
nanostructure of an Au2S/Au core/shell using HAuCl4 and Na2S (Zhou, Honma et al. 
1994; Averitt, Sarkar et al. 1997). This reaction produced products with the optical 
signatures of two bands: (1) 520 nm and (2) near-IR band, which is similar to gold 
nanorods (Schwartzberg, Grant et al. 2007).  
GGS nanoparticle synthesis has been considered due to their novel properties and 
device applications, though initially the focus of the formation of the nanoparticles, 
growth, is more important. Averitt et al. describes the properties of these particles as an 
Au-coated dielectric nanoparticles, or gold nanoshells; the theory relates to describing 
these particles as a dielectric core coated with a metal nanoshell, which occurs naturally, 
in the self-assembly process, during the growth of Au/Au2S nanoparticles (Averitt, 
Sarkar et al. 1997). During the development of nanoparticle growth, while using HAuCl4 
and Na2S, which takes place via reduction in solution, the plasmon absorption peak in the 
nIR region will shifts between 650 to 900 nm or beyond in extreme cases.  
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This unique “red-shift” of the nanoparticle plasmon resonance to have a peak 
wavelength in the nIR regions of the spectrum has high importance for biomedical 
applications, as mentioned in the Application Section (1.2). Averitt et al. published 
results show that the plasmon shift is depended by the size and the dielectric properties of 
the Au2S core with Au shell. Zhou et al. stated that during the later times in the synthesis, 
S2- diffuses through the thin/thick gold shell and reduces the Au2S core, further 
describing that this will result in an increase in the gold shell thickness while the core 
decreasing in size. Averitt et al. later described this kinetic scenario as highly unlikely 
due to S2- bring not existence in aqueous solution at any pH. Furthermore, this allowed 
improved understanding of some of the optical properties of Au nanoshells and helped 
model the growth kinetics of these nanoparticles. The results published by Averitt et al. 
indicate that the plasmon peak shift is in two-stage model of nanoparticle growth; first the 
Au2S core, and second then the Au shell formation on top growing linearly over time 
(Averitt, Sarkar et al. 1997). 
Further studies, by Averitt et al., have demonstrated that S2- is not a dominant 
aqueous species and when Na2S is mixed, the S2- reacts with the water to give HS- and 
OH-. From this, the growth of Au coated Au2S nanoparticles were modeled as: 
2AuCl4- + 3HS-  2Au + 3S + 3H+ + 8 Cl-              (2)(Averitt, Sarkar et al. 1997) 
Both Au and Au-coated Au2S nanoparticles are grown, due to the Au and S being 












CHAPTER 2:  DIASYNTH 
2.1 Introduction 
Chemistry can essentially be divided into three categories: the study of 
structures, equilibrium, and reaction rates (Conners 1990). According to Conners 
et al., chemical structures are described using quantum mechanics, equilibrium is 
studied by statistical mechanics and thermodynamics, and the study of rates 
relates with kinetics. Kinetics can be split into physical kinetics, which deals with 
physical phenomena, such as diffusion and viscosity; while the chemical kinetics 
deals with the rates of chemical reactions, including both covalent and covalent 
bond changes.  
The rate of the reaction (Equation 2) is defined as how fast or slow a 
reaction proceeds to complete the reaction.  
   aA + bB  cC + dD                                           (3) 
There are several factors that can play an important role in affecting the rate of a 
reaction: concentration of reactants, physical state of the reactants, temperature at 
which the reaction takes occurs, and the use of a catalyst (Conners 1990; 
Silberberg 2006).  
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• Concentration of reactants – The more molecules present in the 
system, the more frequently the molecules will collide; therefore, the 
reaction occurs at an accelerated speed (Silberberg 2006).  
• Physical state – depending on the state of the sample, it can mix 
quickly, or require an outside source to aid in mixing (Silberberg 
2006).  
• Temperature – at higher temperatures samples are more likely to 
collide to each other by affecting the kinetic energy of the molecules 
(therefore the energy of collision) (Silberberg 2006). 
• Catalyst – increases a reaction without being consumed by the reaction 
itself; the catalyst effects a lower activation energy and therefore 
increasing the reaction rate (Silberberg 2006).  
2.2 Current methods & DiaSynth 
With the use of Na2S2O3, GGS nanoparticles are more stable and can be 
used for different applications as mentioned above. However, in therapeutic 
applications such as nIR photothermal therapy (Gobin, Watkins et al. 2010) or 
drug delivery via nIR irradiation (Ren and Chow 2003), Gobin et al. reported that 
colloidal gold formation during the self-assembly process are considered a 
contaminant and must be removed. Not only does this reduce the total amount of 
beneficial particles available, but increase endothelial uptake of non-therapeutic 
particles, and can increase immune response (Raschke, Brogl et al. 2004; Gobin, 
Watkins et al. 2010). Traditionally, colloidal gold particles are removed via multi-
step centrifugation (Gobin, Watkins et al. 2010), which is not only time 
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consuming but inefficient as well. This thesis is focused on a novel synthesis to 
produce high yield and manufacturing large quantities of nIR GGS nanoparticles 
with desired near infrared peak (nIR) that can be used for therapeutic applications.  
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The importance of the nIR region in medicine, by using nanoparticle 
technology, is due to the high transmission and low absorption of light, between 
650 and 900 nm, by native tissue components such as water and hemoglobin 
(Gobin, Lee et al. 2007; Day, Bickford et al. 2010). The nIR light has minimal 
interference with tissue and only affects samples which absorb nIR light, which 
enables minimally invasive imaging and treatment (Lowery, Gobin et al. 2006; 
Huang, Jain et al. 2007; Gobin, Watkins et al. 2010; Sun, Zhang et al. 2012). 
AuNPs can be used to diagnose, specifically target, and photo-thermally treat 
tumors by localized hyperthermia using specific nIR lasers matching the peak 
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resonance of the nanoparticles (Lowery, Gobin et al. 2006; Huang, Jain et al. 
2007; Gobin, Watkins et al. 2010; Sun, Zhang et al. 2012).  
 
The current method for producing nIR GGS nanoparticles using Na2S2O3, which 
is based on a single step procedure, results in a low yield of nIR particles compared to 
colloidal gold. We define this as a ratio of the absorbance of peaks, RnIR/Au , of the nIR 
region (700 – 900 nm) relative to the colloidal gold peak (~530 nm) as a relative measure 
of the yield of nIR particles. Once the GGS particles have been synthesized, colloidal 
gold is then removed via a multi-step centrifugation process (Figure 3), although this 
Figure 3: Spectral profile of the GGS nanoparticles with traditional single step 
self-assembly process, black line represents particles as made with RnIR/Au = 0.83, 
while the red line is the particles after multi-step centrifugation with RnIR/Au = 1.95. 














 After 3X Centrifugation
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reduces the non-nIR fractions, the overall yield is reduced at each centrifugation step, in 
end dramatically reducing the yield. The multi-step centrifugation process starts with 
using 25 mL of GGS nanoparticles that are synthesized, and using in a 50 mL 
centrifugation tube, they are centrifuged at 1100 g for 20 min. Next, the pellet was saved 
and the supernatant was re-spun at the same condition for two more times. The pellet 
from the second and third spin was combined with the first; this is to maximize the pellet 
collection and overall yield as depicted in Figure 3. Overall, three centrifugation steps 
(3X centrifugation) was necessary to reduce the colloid peak to a minimum. Also, it is 
important to note that using higher forces during centrifugation of the GGS nanoparticles 
can result in a solid pellet of the nanoparticles, this would reduce the overall yield.  
2.3 DiaSynth – optimized synthesis of gold / gold-sulfide nanoparticles 
By slight modification in synthesis of GGS nanoparticles, using Na2S2O3 instead 
of Na2S, and including results published by Averitt, Sarkar, and Schwartzberg et al. with 
equations (1 & 3), we have formulated equation (4) – unbalanced.  
HAuCl4*3H2O + Na2S2O3*5H2O =                                 
Au2S + Au + Au2S/Au (nanoshell) + S+ + SO42- + NaCl + SO32- +   H+ + S2O62- + Cl- + 
Na+     (4) 
However, in order to shift the equilibrium or kinetics to this system, there are several 
available options. For example, the use of heat can increase the rate of reaction or the 
kinetics (as mentioned in Section 2.1), and by factoring heat into the reaction there is a 
possibility that the reaction would favor the formation of nIR absorbing particles and 
increasing the quality ratio. For this thesis, by combining published methods for single-
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step self-assembly of GGS nanoparticles, and dialysis simultaneously (DiaSynth), forcing 
ion-exchange (by removing reactants or products), the equilibrium of the reaction can be 
shifted to favor the formation of nIR absorbing particles. The DiaSynth technique will 
minimize production of AuNPs with 530 nm resonance (colloidal gold), resulting in an 
increase of yield of nIR particles and a population of nanoparticles that require minimum 
further processing for usage as a therapeutic agent. In addition, peak optical property 
shifts due to removal of some of the non-nIR resonant population. The DiaSynth method 
can increase the yield of the synthesis to have a ratio of 1.7 – 2.36; thus, centrifugation 


















2.4.1 Traditional One-Step Method 
 
The purpose of this experiment is synthesis a batch of AuNPs using one-
step self-assembly process with HAuCl4 and Na2S2O3; followed by a 3x 
centrifugation to purify the sample.  
2.4.1.1 Protocol 
 
Hydrogen tetrachloroaurate (III) trihydrate (chloroauric acid, 
HAuCl4*3H2O) was purchased from Alfa Aesar and diluted to a concentration of 
2 mM (HAuCl4, gold solution). Sodium Thiosulfate (Na2S2O3) was prepared at a 
concentration of 3 mM. Next, at a volumetric ratio of 2.58 
(HAuCl4*3H2O:Na2S2O3), HAuCl4*3H2O and Na2S2O3 are mixed and reacted at 
room temperature to allow for self-assembly of AuNPs. Next, spectral scans were 
obtained after an hour of the self-assembly synthesis at room temperature (RT), 
using a UV/Vis spectrophotometer (Carey 50 Varian). A Malvern Zetasizer 




2.4.1.2 Data/Analysis   
 
  As made After 3X Centrifugation 





   


















 After 3X Centrifugation
Figure 4: Normalized absorbance of GGS nanoparticles with traditional single step 
self-assembly process, the black line represents nanoparticles as made with RnIR/Au 
= 0.83 (As made), while the red line is the nanoparticles after multi-step 






From the given data (Section 2.1.2) using the parameters described in 
Section 2.1.1, we can see that quality ratio, described in Chapter 1, of the as made 
sample (one-step self-assembly process) has a poor RnIR/Au = .83. Next, after the 
3X centrifugation to purify the sample the RnIR/Au increased to 1.95, indicating 




































2.4.2 GGS “Sweep”  
 
The purpose of this experiment is to run a “sweep” on GGS nanoparticle 
synthesis on small scale using one-step self-assembly process with HAuCl4 and 
Na2S2O3 to see the difference the optimal peak of GGS nanoparticles for 
DiaSynth.  A “sweep” is defined has a standard one-step self-assembly process, 




In 6 separate 50 mL centrifugation tubes, add 11 mL of 2 mM HAuCl4 and 
3 mM Na2S2O3 ranging from 1 mL to 7 mL in 1 mL increments in each tube 
separately. Next, spectral scans were obtained after an hour of the self-assembly 








































Figure 5: GGS nanoparticle synthesis sweep using 11 mL of 2 mM HAuCl4 + X 






Once the sweep was complete, the spectral profile was taken for each of 
the samples.  Figures 5 & 6 show the spectral profile on each sample; from that it 
was determined that it would be optimal to work in the range of 2 mL – 4 mL of 3 


























Figure 6: GGS nanoparticle synthesis sweep using 11 mL of 2 mM HAuCl4 + X 
mL of 3 mM Na2S2O3 in 0.5 mL increments (from 2.5-5). 
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2.4.3 GGS Sweep on Oven Based Temperature Synthesis 
The purpose of this experiment is to run a sweep on GGS nanoparticle 
synthesis on small scale using one-step self-assembly process with HAuCl4 and 
Na2S2O3; however, the samples were synthesized inside a temperature controlled 
oven. Increasing the temperature should drive the reaction faster, which ultimately 
would favor the formation of the nIR particles.  
2.4.3.1 Protocol 
 In six separate 50 mL centrifugation tubes, add 11 mL of 2 mM HAuCl4 
and 3 mM Na2S2O3 ranging from 2.5 mL to 5 mL in 0.5 mL increments in each 
tube separately. Once the samples were mixed, they were added to an oven at 
37°C and reacted for 1 hr. The sweep was repeated again, except using an over at 
65°C. All the samples were compared to the sweep done in Section 2.4.2. Next, 
spectral scans were obtained after an hour after the self-assembly process using a 
UV/Vis spectrophotometer (Carey 50 Varian). 


















2.4.3.2  Data/Analysis 
 
  




















Figure 7: GGS nanoparticle synthesis sweep using 11 mL of 2 mM HAuCl4 + X 
mL of 3 mM Na2S2O3 in 0.5 mL increments (from 2.5-5) at 37°C in an oven. 
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Figure 8: GGS nanoparticle synthesis sweep using 11 mL of 2 mM HAuCl4 + 
X mL of 3 mM Na2S2O3 in 0.5 mL increments (from 2.5-5) at 65°C in an oven. 
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  Int Ratios (HAuCl4/Na2S2O3) 
nIR Wavelength 
Peak (nm) Quality Ratio 
RT 
4.40 N/A N/A 
3.67 995 1.675 
3.14 901 1.398 
2.75 852 1.126 
2.44 807 0.895 
2.20 779 0.730 
37 CO 
4.40 1025 0.773 
3.67 987 1.665 
3.14 901 1.370 
2.75 859 1.135 
2.44 801 0.885 
2.20 785 0.713 
65 CO 
4.40 N/A N/A 
3.67 897 1.432 
3.14 822 1.203 
2.75 813 0.990 
2.44 807 0.929 
2.20 787 0.770 
























Figure 9: Scatter plot (data from Table 4) of the initial ratio (HAuCl4 : Na2S2O3) used vs the nIR peak at the end of the reaction 























Figure 10: Scatter plot (data from Table 4) of the initial ratio (HAuCl4 : Na2S2O3) used vs the RnIR/Au  at the end of the reaction 
is the given three controls. 
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2.4.3.3 Conclusion  
Once the sweep was complete, the spectral profile was taken for each of 
the samples.  Figures 7 & 8 show the spectral profile on each sample; from that it 
was determined that it would be optimal to work in the range of 2 mL – 4 mL of 3 
mM Na2S2O3 to be mixed with 2 mM HAuCl4, same as the data reported in 
Section 2.4.2. The sample will be tested in a water bath to see if it will aid in the 




2.4.4 GGS Synthesis in Water Bath & Oven - Temperature Controlled 
Environment 
The purpose of this experiment is to synthesize GGS nanoparticle on small 
scale using one-step self-assembly process with HAuCl4 and Na2S2O3; however, 
the samples were synthesized inside a temperature controlled oven and water bath 
(repeat of experiment in Section 2.4.3).  
 
2.4.4.1 Protocol 
 Fill a 1 L beaker with 800 mL of DI water and heat the water to 37°C or 
65°C. Next, using a 50 mL centrifugation tubes, add a mixture of 11 mL of 2 mM 
HAuCl4 and 2 or 3 mL of 3 mM Na2S2O3, and let the sample react for 1 hour at 
RT, 37°C, and 65°C. Next, spectral scans were obtained after an hour of the self-
assembly synthesis at room temperature (RT), 37°C, and 65°C. Next, spectral 
scans were obtained after an hour after the self-assembly process using a UV/Vis 
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 65 Oven 11+2
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Figure 11: GGS nanoparticle synthesis using 11 mL of 2 mM HAuCl4 + 2 mL of 3 


















 37 Oven 11+3
 65 Oven 11+3
 37 WB 11+3
 65 WB 11+3
 
Figure 12: GGS nanoparticle synthesis using 11 mL of 2 mM HAuCl4 + 3 mL of 3 
mM Na2S2O3  in a water bath and an oven at 35°C or 65°C. 
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 Samples Int Ratio 
nIR Wavelength 
Peak (nm) Quality Ratio 
RT 
5.5 N/A N/A 
3.67 990 1.663 
37C Oven 
5.5 N/A N/A 
3.67 919 1.164 
65C Oven 
5.5 N/A N/A 
3.67 902 1.271 
37C WB 
5.5 N/A N/A 
3.67 930 1.496 
65C WB 
5.5 N/A N/A 
3.67 826 1.270 




Once the self-assembly process was complete, the spectral profile was 
taken for each of the samples.  Figures 11 & 12 show the spectral profile on each 
sample; from that it was determined that it using the water bath shows better 
results for 11+3, and had better quality ratio.   
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2.4.5 GGS Synthesis in Water Bath - Temperature Controlled Environment 
 
The purpose of this experiment is to synthesize GGS nanoparticle on small 
scale using one-step self-assembly process with HAuCl4 and Na2S2O3; however, 
the samples were synthesized inside a temperature controlled water bath (repeat 
of experiment in Section 2.4.3 and 2.4.4). However in those experiments the 




 Fill a 1 L beaker with 800 mL of DI water and heat the water to 37°C 
(WB) or 100°C (HB). Next, using a 50 mL centrifugation tubes, add a mixture of 
8 mL, 9 mL, 10 mL, or 11 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3, and 
let the sample react for 1 hour at RT, 37°C, and 100°C. Next, spectral scans were 
obtained after an hour of the self-assembly synthesis at room temperature (RT), 






























Figure 13: Spectral profile of the RT synthesis, using a mixture of 8 mL, 9 mL, 10 




























Figure 14: Spectral profile of the 37°C water bath synthesis, using a mixture of 8 mL, 9 
mL, 10 mL, or 11 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3. 
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Figure 15: Spectral profile of the 100°C water bath synthesis, using a mixture of 8 







Peak (nm) Quality Ratio 
RT 
2.67 912 1.103 
3.00 955 1.458 
3.33 953 1.591 
3.67 964 1.700 
37 C 
2.67 863 1.064 
3.00 908 1.265 
3.33 851 1.380 
3.67 908 1.858 
100 C 
2.67 716 0.789 
3.00 736 0.817 
3.33 749 0.908 
3.67 720 1.193 


























Figure 16: Scatter plot (data from Table 6) of the initial ratio (HAuCl4 : Na2S2O3) used vs the RnIR/Au  at the end of the reaction 




















Int Ratio (Au/Na2S2O3) 
RT
 
Figure 17: Scatter plot (data from Table 6) of the initial ratio (HAuCl4 : Na2S2O3) used vs the nIR peak at the end of the 





Once the self-assembly process was complete, the spectral profile was taken for 
each of the samples.  Figures 13, 14, & 15, show the spectral profile on each sample. At 
higher temperatures samples are colliding faster to each other, which ultimately affecting 
the kinetic energy of the molecules, and driving the reaction. For the series of 
temperature studies, the kinetics was changed and shown to have an RnIR/Au > 1.2. Most 
of the reaction show that using the 11+3 samples has a better ratio, using the initial for 
the DiaSynth studies could be beneficial.   
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2.4.6 DiaSynth  
 
The purpose of this experiment is to synthesize a batch of AuNPs with 
HAuCl4 and Na2S2O3 using the DiaSynth method, dialyzed against DI water at 
room temperature. Also, HAuCl4 dialyzed against Na2S2O3 to see the kinetics and 
equilibrium shift of two different reactions. 
 
2.4.6.1 Protocol  
 
Fill a 1 L beaker with 800 mL of DI water and place stir bar inside. Next, 
using a 3500 Da MWCO Dialysis membrane, add a mixture of 11 mL of 2 mM 
HAuCl4 (first in the bag) and 3 mL of 3 mM Na2S2O3 (second after the gold 
solution had been added), and let the sample dialyze for 1 hour (Sample 1). 
Separately, fill a 1L beaker with 3 mM Na2S2O3. Next to that, add 25 mL of 2 
mM HAuCl4 in a 3500 Da MWCO Dialysis membrane and let it react for 2.5 
hours (Sample 2). For a non-dialysis sample, 11 mL of 2 mM HAuCl4 and 3 mL 
of 3 mM Na2S2O3 are mixed in a 50 mL tube and reacted for 1 hr as well (Sample 
3). Next, spectral scans were obtained after an hour of the self-assembly synthesis 
at room temperature (RT), using a UV/Vis spectrophotometer (Carey 50 Varian). 
A Malvern Zetasizer (ZS90) was used to characterize the GGS nanoparticles 









Figure 18: Normalized absorbance and spectral profile of GGS nanoparticles 
synthesized using various parameters. (Sample 1, black-square line) 11 mL of 2 
mM HAuCl4 mixed with 3 mL of 3 mM Na2S2O3 dialyzed against DI water with 
RnIR/Au = 1.4. (Sample 2) 25 mL of 2 mM HAuCl4 dialyzed against 1 L of Na2S2O3 
for 2.5 hrs (blue-triangle line). (Sample 3, red-circle line) Non-dialyzed sample 
using 11 mL of 2 mM HAuCl4 mixed with 3 mL of 3 mM Na2S2O3 with RnIR/Au = 
1.53. 
















(A) (B) (C) (D) 
(E) (F) (G) (H) 
Figure 19: Image of Non-Dialysis synthesis and dialyzed synthesis over 1 hr time period. (A - D) Image of non-dialyzed 
sample at 30 secs, 5 mins, 30 mins, and 1 hr, respectfully. (E - F) Image of Dialyzed sample at 30 secs, 5 mins, 30 mins, and 





From the given data, we can see that 11 mL of 2 mM HAuCl4 mixed with 
3 mL of 3 mM Na2S2O3 in a 3500 Da MWCO Dialysis membrane, dialyzed 
against DI water has the best nIR RnIR/Au = 1.4; while the non-dialyzed sample had 
RnIR/Au = 1.53. Sample dialyzed against Na2S2O3 had pure colloid formation, and 





2.4.7 DiaSynth (repeat of 2.4.6 with extended time) 
 
The purpose of this experiment is to synthesize a batch of AuNPs with 
HAuCl4 and Na2S2O3 using the DiaSynth method, dialyzed against DI water at 
room temperature. Also, HAuCl4 dialyzed against Na2S2O3 for an extended period 
of time to see the kinetics and equilibrium shift of two different reactions.  
2.4.7.1 Protocol  
 
Fill a 1 L beaker with 800 mL of DI water and place stir bar inside. Next, 
using a 3500 Da MWCO Dialysis membrane, add a mixture of 11 mL of 2 mM 
HAuCl4 (first in the bag) and 3 mL of 3 mM Na2S2O3 (second after the gold 
solution had been added), and let the sample dialyze for 1 hour (Sample 1). 
Separately, fill a 1L beaker with 3 mM Na2S2O3. Next to that, add 25 mL of 2 
mM HAuCl4 in a 3500 Da MWCO Dialysis membrane and let it react for 5 hours 
(Sample 2 & 3). For a non-dialysis sample, 11 mL of 2 mM HAuCl4 and 3 mL of 
3 mM Na2S2O3 are mixed in a 50 mL tube and reacted for 1 hr as well (Sample 4). 
Next, spectral scans were obtained after an hour of the self-assembly synthesis at 
room temperature (RT), using a UV/Vis spectrophotometer (Carey 50 Varian). A 
Malvern Zetasizer (ZS90) was used to characterize the GGS nanoparticles surface 



















From the given data, we can see that 11 mL of 2 mM HAuCl4 mixed with 
3 mL of 3 mM Na2S2O3 in a 3500 Da MWCO Dialysis membrane, dialyzed 
against DI water, has the best nIR RnIR/Au = 1.4; while the non-dialyzed sample 
















Figure 20: Non-normalized absorbance and spectral profile of GGS 
nanoparticles synthesized using various parameters. (Sample 1, black-square 
line) 11 mL of 2 mM HAuCl4 mixed with 3 mL of 3 mM Na2S2O3 dialyzed against 
DI water with RnIR/Au = 1.4. (Sample 2 & 3, respectively) 25 mL of 2 mM HAuCl4 
dialyzed against 1 L of Na2S2O3 for 2.5 hrs (blue-triangle line) and 5 hrs (pink 
line-triangle-down line), both with RnIR/Au < 1. (Sample 4, red-circle line) Non-
dialyzed sample using 11 mL of 2 mM HAuCl4 mixed with 3 mL of 3 mM 
Na2S2O3 with RnIR/Au = 1.59. 
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had RnIR/Au = 1.59. The extended dialysis sample dialyzed against Na2S2O3 had 





2.4.8 DiaSynth - with time and int. ratio variation 
 
The purpose of this experiment is to synthesize a batch of AuNPs with 
HAuCl4 and Na2S2O3 using the DiaSynth method, dialyzed against DI water at 
room temperature.  However, from the previous studies, Section 2.4.6 & 2.4.7, 
samples with 11 mL of 2 mM HAuCl4 mixed with 3 mL of 3 mM Na2S2O3 in a 
3500 Da MWCO Dialysis membrane showed the best result. The experiment will 
use the sample initial ratio (11+3, 11 mL of 2 mM HAuCl4 mixed with 3 mL of 3 
mM Na2S2O3 or HAuCl4:Na2S2O3, used for dialysis) as well as 11+2, while 




Fill 4 - 1 L beaker with 800 mL of DI water and place stir bar inside. Next, 
using a 3500 Da MWCO Dialysis membrane, add a mixture of 11 mL of 2 mM 
HAuCl4 (first in the bag) and 2 (Sample 1) or 3 (Sample 2) mL of 3 mM Na2S2O3 
(second after the gold solution had been added), and let the sample dialyze for 1 
(Sample 1 & 2) hr & 2 hrs (Sample 3 & 4). For a non-dialysis sample, 11 mL of 2 
mM HAuCl4 and 2 (Sample 5) or 3 (Sample 6) mL of 3 mM Na2S2O3 are mixed 
in a 50 mL tubes and reacted for 1 hr. Next, spectral scans were obtained after an 
hour of the self-assembly synthesis at room temperature (RT), using a UV/Vis 
spectrophotometer (Carey 50 Varian). A Malvern Zetasizer (ZS90) was used to 



































Figure 21: Normalized absorbance and spectral profile of GGS nanoparticles 
synthesized using various parameters. (Sample 1 & 3, red-circle & blue-triangle 
line respectively) 11 mL of 2 mM HAuCl4 mixed with 2 mL of 3 mM Na2S2O3 
dialyzed against DI water for 1 & 2 hrs, respectively,  with RnIR/Au = 2.01 & 1.65, 
respectively. (Sample 5, black-square line) Non-dialyzed sample using 11 mL of 2 
mM HAuCl4 mixed with 2 mL of 3 mM Na2S2O3 with RnIR/Au  = N/A, due to the 







Using the 11 mL of 2 mM HAuCl4 and 2 mL of 3 mM Na2S2O3 dialyzed 
against DI Water for 2 hrs has a RnIR/Au = 1.65, not only does this show that 
dialyzing for 1 hr shifts the equilibrium of the synthesis, but further (extended 
time) dialysis shifts the equilibrium even more on the 2000 Da MWCO Dialysis 
membrane. The initial ratios that are being using should be used  
 














Figure 22: Normalized absorbance and spectral profile of GGS nanoparticles 
synthesized using various parameters. (Sample 2 & 4, red-circle & blue-triangle 
line respectively) 11 mL of 2 mM HAuCl4 mixed with 3 mL of 3 mM Na2S2O3 
dialyzed against DI water for 1 & 2 hrs, respectively,  with RnIR/Au = 1.58 & 1.49, 
respectively. (Sample 6, black-square line) Non-dialyzed sample using 11 mL of 2 
mM HAuCl4 mixed with 3 mL of 3 mM Na2S2O3 with RnIR/Au  = 1.53. 
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2.4.9 DiaSynth - using high temperature 
 
The purpose of this experiment is to synthesize a batch of AuNPs with 
HAuCl4 and Na2S2O3 using the DiaSynth method, dialyzed against DI water at 




Fill 4 - 1 L beaker with 800 mL of DI water, two with DI water at 100° C, 
one with DI water at 65° C, and one with room temperature (RT) DI water, and 
place stir bar inside. Next, using a 3500 Da MWCO Dialysis membrane, add a 
mixture of 11 mL of 2 mM HAuCl4 (first in the bag) and 3 mL of 3 mM Na2S2O3 











When placing the dialysis membrane in the DI water at 100° C, the sample 
started to react very fast and changed colors, therefore one sample ran for 5 mins  
(blue line) and the other for 15 mins (pink line). From the spectral profile, 
overtime samples had just pure colloid formation. Compared to the RT sample, 
this is relative close to what was previously synthesized; also the sample with DI 
water at 65° C (reacted for the full 1 hr) had similar results to the 100 ° C sample.   














Figure 23: Normalized absorbance and spectral profile of GGS nanoparticles 
synthesized using DiaSynth method with various temperature of DI water. 
(Black-square line) Sample with RT DI water has highest RnIR/Au  = 1.48. The rest 
of the controls with high DI water temperature had RnIR/Au  < 1. 
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2.4.10 DiaSynth - 1,2 step  
 
The purpose of this experiment is to synthesize a batch of AuNPs with 
HAuCl4 and Na2S2O3 using the DiaSynth method, dialyzed against DI water with 
the one-step and two-step techniques described in the introduction section, except 
instead of using a 1 L beaker, the experiment will use an 8 L bucket. Also, from 
the previous experiments the AuNPs are aggregating, indicating that the particles 
are not stable, therefore once the experiment is finished chitosan (CS) will be 




Fill 2 – 8 L beaker with 7.5 – 8 L of DI water and place stir bar inside. 
Next, using a 3500 Da MWCO Dialysis membrane, add a mixture of 11 mL of 2 
mM HAuCl4 (first in the bag) and 3 mL of 3 mM Na2S2O3 (second after the gold 
solution had been added), and let the sample dialyze for 1 hour (Sample 1). Next 
for the two-step reaction, 4 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 is 
reacted for 30 secs, in a 3500 Da MWCO Dialysis membrane, and 7 mL of 2 mM 
HAuCl4 is additionally added in the 3500 Da MWCO Dialysis membrane and 
allow reaction for an hour (Sample 2). For the non-dialyzed samples, 11 mL of 2 
mM HAuCl4 and 3 mL of 3 mM Na2S2O3 are mixed in a 50 mL tube and reacted 
for 1 hr for the one-step process (Sample 3); additionally, a two-step process is 
done in the similar fashion as described above (Sample 4). Next, once the reaction 




























Figure 24: Normalized absorbance and spectral profile of GGS nanoparticles 
synthesized using DiaSynth method with one-step (Sample 1, blue-triangle line), 
two-step (Pink-triangle-down line), and Non-dialyzed samples, one step (Sample 
3, black-square line) and two-step (red-circle line). The nIR peak and ratio are 


































Figure 25: Normalized absorbance and spectral profile of GGS nanoparticles 
synthesized using DiaSynth method with one-step (Sample 1, blue-triangle line), 
two-step (Pink-triangle-down line), and Non-dialyzed samples, one step (Sample 
3, black-square line) and two-step (red-circle line), after adding in the CS 
overnight. The nIR peak and quality ratio are reported in Table 2. 
74 
 
  Controls nIR Peak Ratio 
Before CS 
Sample 1 805 1.66 
Sample 2 842 1.85 
Sample 3 856 1.40 
Sample 4 1095 2.04 
After CS 
Sample 1 750 1.43 
Sample 2 784 1.49 
Sample 3 807 1.27 





Using the DiaSynth method, compared to traditional method including 2-
step method, the results show that DiaSynth method has high quality ratio. The 
ratios and the nIR peak of the different parameters are provided in Table 7. Next, 
in order to stabilize the AuNPs, CS was added to them over night and spectral 
profile was measured the following day which show there was no significant 
changes; therefore the particles are more stable.      
Table 6: nIR peak and the ratios of each sample before and after adding the CS. 
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2.4.11 DiaSynth – repeat of Section 2.4.10 
 
 
The experiment in Section 2.4.10 is being repeated after washing the 
dialysis membrane very carefully. The purpose of this experiment is to synthesize 
a batch of AuNPs with HAuCl4 and Na2S2O3 using the DiaSynth method, 
dialyzed against DI water at room temperature. However, from the previous 
studies, Section 2.3 & 2.4, samples with 11 mL of 2 mM HAuCl4 mixed with 3 
mL of 3 mM Na2S2O3 in a 3500 Da MWCO Dialysis membrane showed the best 
result. The experiment will use the sample initial ratio (11+3) as well as 11+2, 
while extending the dialysis time to 4 hrs and using a 2000 Da MWCO Dialysis 




Fill 6 – 8 L bucket with 7.5 – 8 L of DI water and place stir bar inside. 
Next, using 3 of the 6 - 8 L buckets, add, in three separate 3500 Da MWCO 
Dialysis membrane, a mixture of 11 mL of 2 mM HAuCl4 (first in the bag) and 3 
mL of 3 mM Na2S2O3 (second after the gold solution had been added), and let the 
sample dialyze for 1, 2, and 4 hours in separate buckets (Sample 1, 2, and 3, 
respectively). Repeat everything from using the other three 8 L bucket, except 
using 2000 Da MWCO Dialysis membrane for 1, 2, and 4 hours in separate 
buckets (Sample 4, 5, and 6, respectively). Then for a non-dialysis sample, 11 mL 
of 2 mM HAuCl4 and 2 (Sample 7) or 3 (Sample 8) mL of 3 mM Na2S2O3 are 
mixed in a 50 mL tubes and reacted for 1 hr. Next, spectral scans were obtained 
after an hour of the self-assembly synthesis at room temperature (RT), using a 
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UV/Vis spectrophotometer (Carey 50 Varian). A Malvern Zetasizer (ZS90) and 
TEM (FEI Tecnai F20) were used to characterize the GGS nanoparticles surface 

















































Figure 26: Normalized absorbance and spectral profile of GGS nanoparticles 
synthesized using DiaSynth method with 2000 MWCO Dialysis membrane, a 
mixture of 11 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 is added. The 
sample were dialyze for 1 (red-circle line), 2 (blue-triangle line), and 4 (pink-
triangle-down line). Non-dialyzed sample using 11 mL of 2 mM HAuCl4 mixed 
with 3 mL of 3 mM Na2S2O3 is used as a control (black-square line). nIR peak 
























































Figure 27: Normalized absorbance and spectral profile of GGS nanoparticles 
synthesized using DiaSynth method with 3500 MWCO Dialysis membrane, a 
mixture of 11 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 is added. The 
sample were dialyze for 1 (red-circle line), 2 (blue-triangle line), and 4 (pink-
triangle-down line). Non-dialyzed sample using 11 mL of 2 mM HAuCl4 mixed 
with 3 mL of 3 mM Na2S2O3 is used as a control (black-square line). nIR peak 




   














Figure 28: Normalized absorbance and spectral profile of GGS nanoparticles 
synthesized using DiaSynth method with 2000 MWCO Dialysis membrane, a 
mixture of 11 mL of 2 mM HAuCl4 and 2 mL of 3 mM Na2S2O3 is added. The 
sample were dialyze for 1 (red-circle line), 2 (blue-triangle line), and 4 (pink-
triangle-down line). Non-dialyzed sample using 11 mL of 2 mM HAuCl4 mixed 
with 2 mL of 3 mM Na2S2O3 is used as a control (black-square line). nIR peak 



















Figure 29: Normalized absorbance and spectral profile of GGS nanoparticles 
synthesized using DiaSynth method with 3500 MWCO Dialysis membrane, a 
mixture of 11 mL of 2 mM HAuCl4 and 2 mL of 3 mM Na2S2O3 is added. The 
sample were dialyze for 1 (red-circle line), 2 (blue-triangle line), and 4 (pink-
triangle-down line). Non-dialyzed sample using 11 mL of 2 mM HAuCl4 mixed 
with 2 mL of 3 mM Na2S2O3 is used as a control (black-square line). nIR peak 
and quality ratio are reported in Table 9. 
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 Samples (11+3) 
nIR Wavelength Peak 
(nm) Quality Ratio 
Non-Dialysis 1 hr 959 1.539 
2000 Da 
MWCO Dialysis 
1 hr 899 1.357 
2 hr 926 1.416 
4 hr 930 1.444 
3500 Da 
MWCO Dialysis 
1 hr 816 1.527 
2 hr 815 1.620 
4 hr 819 1.573 
 
Table 7: nIR peak and the quality ratios of each sample from Figure 26 and 27.  
 
 Samples (11+2) nIR Wavelength Peak (nm) Quality Ratio 
Non-Dialysis 1 hr N/A N/A 
2000 Da MWCO 
Dialysis 
1 hr N/A N/A 
2 hr N/A N/A 
4 hr N/A N/A 
3500 Da MWCO 
Dialysis 
1 hr 1027 2.005 
2 hr 773 1.678 
4 hr 852 1.820 
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Figure 29: Graph of the nIR peak of samples from Tables 8 & 9, X-axis is dialysis time (in hrs) for each control, Y-Axis 




























Figure 30: Graph of the quality ratio of samples from Tables 8 & 9, X-axis is dialysis time (in hrs) for each control, 
Y-Axis is the initial ratio used to synthesize the AuNPs, and Z-axis quality ratio of the AuNPs after the synthesis.. 
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Figure 31: TEM images of Dialyzed and non-dialyzed samples. Top row – Non-dialysis sample, Middle row – 
DiaSynth using 2000 MWCO Dialysis membrane, and Bottom row DiaSynth using 3500 MWCO Dialysis membrane. 





After noticing that dialysis membrane are soaked a preservative called 
sodium azide, which could potentially be the cause of the aggregation, the dialysis 
membrane are thoroughly washed with DI water, and then placed in the DI water 
with the HAuCl4 and Na2S2O3. This experiment was repeated from Section 2.5, 
using DiaSynth along with the controls shown in Tables 8 & 9. The data shows 
that using the 3500 Da MWCO Dialysis membrane with a mixture of 11 mL of 2 
mM HAuCl4 and 3 mL of 3 mM Na2S2O3 dialyzed for 1, 2, or 4 hrs, has the best 
RnIR/Au  = 1.57, 1.62, and 1.57, respectfully. The TEM samples were prepared 
using the 1 hr samples for each control on 11+3 (non-dialysis and 2000 & 3500 
Da MWCO Dialysis membrane). From the TEM images, it should that there is 
less production of the colloidal particles when using the DiaSynth method.         
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2.4.12 DiaSynth Sweep  
 
The purpose of this experiment is to run a sweep on GGS nanoparticle 
synthesis with DiaSynth method, using 11 mL of 2 mM HAuCl4 mixed with 
various “X mL” of 3 mM Na2S2O3 in 2000 and 3500 Da MWCO Dialysis 




Fill an 8 L bucket with 7.5 – 8 L of DI water and place stir bar inside. 
Next, in a 3500 Da MWCO Dialysis membrane, a mixture of 11 mL of 2 mM 
HAuCl4 (first in the bag) and 2.5 mL to 5 mL in 0.5 mL increments mL of 3 mM 
Na2S2O3 (second after the gold solution had been added), and let the sample 
dialyze for 1 hr. Repeat the experiment, except using 2000 Da MWCO Dialysis 
membrane. Then for a non-dialysis sample, 11 mL of 2 mM HAuCl4 and 2.5 mL 
to 5 mL in 0.5 mL increments of 3 mM Na2S2O3 are mixed in a 50 mL tubes and 
reacted for 1 hr (Table 10 shows the list of the controls used in this experiment). 
In 6 separate 50 mL centrifugation tubes, add 11 mL of 2 mM HAuCl4 and 3 mM 
Na2S2O3 ranging from 2.5 mL to 5 mL in 0.5 mL increments in each tube 
separately. Next, spectral scans were obtained after an hour of the self-assembly 
synthesis at room temperature (RT), using a UV/Vis spectrophotometer (Carey 50 
Varian). A Malvern Zetasizer (ZS90) was used to characterize the GGS 







































































Figure 32: GGS nanoparticle sweep with DiaSynth method using 11 mL of 2 mM 
HAuCl4 + X mL of 3 mM Na2S2O3 in 0.5 mL increments (from 2.5-5) in a 2000 
MWCO Dialysis membrane. The Black-square, Red-circle, Blue-triangle, Pink-
triangle-down, Green-square, and Purple-triangle-side line represents the 
spectral profile of the samples with 2.5, 3, 3.5, 4, 4.5, and 5 mL of 3 mM Na2S2O3. 




















Figure 33: GGS nanoparticle sweep with DiaSynth method using 11 mL of 2 
mM HAuCl4 + X mL of 3 mM Na2S2O3 in 0.5 mL increments (from 2.5-5) in a 
3500 MWCO Dialysis membrane. The Black-square, Red-circle, Blue-triangle, 
Pink-triangle-down, Green-square, and Purple-triangle-side line represents the 
spectral profile of the samples with 2.5, 3, 3.5, 4, 4.5, and 5 mL of 3 mM 
Na2S2O3. The nIR peak and quality ratio is reported in Table 11. 
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  Int Ratios (HAuCl4/Na2S2O3) 
nIR Wavelength 
Peak (nm) Quality Ratio 
Non-Dialysis 
4.40 N/A N/A 
3.67 995 1.675 
3.14 901 1.398 
2.75 852 1.126 
2.44 807 0.895 
2.20 779 0.730 
2000 Da MWCO 
Dialysis 
4.40 931 1.588 
3.67 928 1.421 
3.14 950 1.436 
2.75 848 1.209 
2.44 771 0.783 
2.20 771 0.787 
3500 Da MWCO 
Dialysis 
4.40 789 1.804 
3.67 816 1.731 
3.14 820 1.621 
2.75 834 1.352 
2.44 789 1.038 
2.20 747 0.787 
 




























Figure 34: Scatter plot (data from Table 11) of the initial ratio (HAuCl4 : Na2S2O3) used vs the nIR peak at the end of the 
















Int Ratio (HAuCl4/Na2S2O3) 
Non-Dialysis
2000 Da MWCO Dialysis
3500 Da MWCO Dialysis
 
Figure 35: Scatter plot (data from Table 11) of the initial ratio (HAuCl4 : Na2S2O3) used vs the RnIR/Au  at the end of the 




From the given data, the sample with 11 mL of 2 mM HAuCl4 mixed with 
2.5 mL of 3 mM Na2S2O3 in a 3500 Da MWCO Dialysis membrane, dialyzed 
against DI water, has the best nIR RnIR/Au = 1.8; while the 2000 Da MWCO 
Dialysis membrane and  non-dialyzed sample has RnIR/Au = 1.58 and N/A, 
respectfully. Future studies will focus on using the 11 mL of 2 mM HAuCl4 





















2.4.13 DiaSynth - using higher MWCO bags 
 
The purpose of this experiment is to synthesize a batch of AuNPs with 
HAuCl4 and Na2S2O3 using the DiaSynth method, dialyzed against DI water at 
room temperature. However, this experiment will use 4 different dialysis 
membrane, 2000 Da MWCO, 3500 Da MWCO, 6000 - 8000 Da MWCO, and 
12000 Da MWCO dialysis membranes.  
 
2.4.13.1 Protocol 
Fill 4 - 8 L bucket with 7.5 – 8 L of DI water and place stir bar inside. 
Next, prepare 4 mixtures of 11 mL of 2 mM HAuCl4 (first in the bag) and 2.5 mL 
of 3 mM Na2S2O3 (second after the gold solution had been added) is added to 
2000 Da MWCO, 3500 Da MWCO, 6000 - 8000 Da MWCO, and 12000 Da 
MWCO dialysis membrane separately, and let the samples dialyze for 1. Then for 
a non-dialysis sample, 11 mL of 2 mM HAuCl4 and 2.5 mL of 3 mM Na2S2O3 is 
mixed in a 50 mL tubes and reacted for 1 hr. Next, spectral scans were obtained 
after an hour of the self-assembly synthesis at room temperature (RT), using a 














Figure 36: Normalized spectral profile of AuNPs synthesized using the 
DiaSynth method with 4 different MWCO bags. 














 2 KDa MWCO Dialysis
 3.5 KDa  MWCO Dialysis  
 6-8 KDa  MWCO Dialysis




Samples nIR Wavelength Peak (nm) Quality Ratio 
Non-Dialysis 1098 2.58 
2KDa MWCO Dialysis 858 1.35 
3.5KDa MWCO Dialysis 748 1.54 
6-8KDa MWCO Dialysis 744 1.57 
12KDa MWCO Dialysis 799 1.65 















Size (nm) 43.64 38.94 41.22 42.25 
Zeta Potential 
(mV) -26.4 -35.2 -29.95 -30.25 
Table 13: Size and zeta measurements of the samples. 
 
2.4.13.3 Conclusion 
From the given data (Figure 37 & Table 12), the sample with 11 mL of 2 
mM HAuCl4 mixed with 2.5 mL of 3 mM Na2S2O3 in a 12000 Da MWCO 
Dialysis membrane, dialyzed against DI water, has the best nIR RnIR/Au = 1.7; 
while the other MWCO Dialysis membrane has a lower RnIR/Au. Future studies 
will focus on using the 11 mL of 2 mM HAuCl4 mixed with 2.5 mL of 3 mM 




2.4.14 DiaSynth – 12 KDa MWCO Sweep 
 
The purpose of this experiment is to run a sweep on GGS nanoparticle 
synthesis with DiaSynth method, using 11 mL of 2 mM HAuCl4 mixed with 
various “X mL” of 3 mM Na2S2O3 in 12000 Da MWCO Dialysis membrane to 
show the best quality ratio. 
 
2.4.14.1 Protocol 
Fill an 8 L bucket with 7.5 – 8 L of DI water and place stir bar inside. 
Next, in a 12000 Da MWCO Dialysis membrane, a mixture of 11 mL of 2 mM 
HAuCl4 (first in the bag) and 2.5 mL to 3.5 mL in 0.5 mL increments mL of 3 
mM Na2S2O3 (second after the gold solution had been added), and let the sample 
dialyze for 1. Next, spectral scans were obtained after an hour of the self-
assembly synthesis at room temperature (RT), using a UV/Vis spectrophotometer 
(Carey 50 Varian). A Malvern Zetasizer (ZS90) was used to characterize the GGS 





















Samples nIR Wavelength Peak (nm) Quality Ratio 
2.5 mL 746 1.904 
3 mL 760 1.458 
3.5 mL 763 1.199 
   Table 14: nIR peak and the quality ratios of each sample from Figure 38. 

















Figure 37: Normalized spectral profile of AuNPs synthesized using DiaSynth 
method  in a 12000 Da MWCO Dialysis membrane, using 11 mL of 2 mM 
HAuCl4 and various amount of 3 mM Na2S2O3 (2.5, 3, and 3.5 mL).  
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          Samples 2.5 mL 3 mL 3.5 mL 
Size (nm) 40.12 43.12 42.19 
Zeta Potential (mV) -32.6 -35.675 -38.75 
    Table 15: Size and zeta measurements of the samples. 
 
2.4.14.3 Conclusion 
Instead of running the dialysis for 1 hr, it was accidently left running for 
1.5 hrs. From the given data (Figure 38 & Table 14), the sample with 11 mL of 2 
mM HAuCl4 mixed with 2.5 mL of 3 mM Na2S2O3 in a 12000 Da MWCO 
Dialysis membrane, dialyzed against DI water, has the best nIR RnIR/Au = 1.9; 





2.4.15 DiaSynth – Dialysate  
Using the DiaSynth method, samples are being dialyzed with a known 
MWCO dialysis membrane. However, it is unclear if the colloidal nanoparticles 
are forming on the outside or whether they get dialyzed out. The purpose of this 
experiment is to synthesize a bath of AuNPs using the DiaSynth method, and 
using rotary evaporator (rotovap) on the dialysate, concentrate the sample down, 
and measure the it for further analyze the sample.  The purpose of the rotovap is 
to gently remove any solvents in the sample, water, by evaporation.  
2.4.15.1 Protocol 
Fill a 1 L beaker with 800 mL of DI water and place stir bar inside. Next, 
in a 12000 Da MWCO Dialysis membrane, a mixture of 11 mL of 2 mM HAuCl4 
(first in the bag) and 2.5 mL of 3 mM Na2S2O3 (second after the gold solution 
had been added), and let the sample dialyze for 1 hr. Once the dialysis is finished, 
removed the dialysate, and rotovap the sample until only 20 mLs of it is left. Then 
for a non-dialysis sample, 11 mL of 2 mM HAuCl4 and 2.5 mL of 3 mM 
Na2S2O3 is mixed in a 50 mL tubes and reacted for 1 hr. Next, spectral scans 
were obtained after an hour of the self-assembly synthesis at room temperature 
(RT), using a UV/Vis spectrophotometer (Carey 50 Varian). A Malvern Zetasizer 
(ZS90) and TEM (FEI Tecnai F20) were used to characterize the GGS 


























 12000 Da MWCO Dialysis
 Dialysate Rotovap Sample 
Figure 38: Normalized spectral profile of Non-Dialyzed, 12000 Da MWCO 






Figure 40: (A) & (B) are the rotovap sample, while (C) & (D) are the 12000 









Size (nm) ~ 40 ~40 2, 78, 188, & 500+ 
Zeta 
(mV) - 38 - 33 - 23 
Peak 
(nm) - 811 530 
Ratio - 1.9 - 
Table 16: nIR spectral peak, quality ratio, size, and zeta measurements of the 
samples, a detailed explanation is given in the conclusion section. 
 
2.4.15.3 Conclusion 
Using the DiaSynth method, AuNPs have been synthesized at a high 
purity. From this experiment, a 12000 Da MWCO Dialysis membrane was used to 
mix 11 mL of 2 mM HAuCl4 with 2.5 mL of 3 mM Na2S2O3. Once the dialysis 
is finished, the dialysate was removed and rotovapped until only 20 mLs of it is 
left. From Table 11, in the Dialysate Rotovap sample, there are multiple sized 
particles; this could be due to the fact that particles colliding and forming large 
aggregations (Figure 39). Next, the Dialysate Rotovap sample has an absorbance 
peak at 530 nm, which is the same peak as the colloidal particles mentioned in the 
Introduction section. This confirms that the colloidal particles are indeed 
dialyzing out of the back and forcing ion exchange, which the ultimately effects 
the quality ratio to form the nIR favoring particles.  
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2.4.16 DiaSynth – Scale up 
Using the DiaSynth method, AuNPs have been synthesized at a high 
purity; however from a manufacturing standpoint, the process must be able to 
scale up in order to create a large bath of AuNPs with high purity and minimal 
processing. This experiment focuses on synthesizing AuNPs with the DiaSynth 
method with double the volume.  
2.4.16.1 Protocol 
Fill an 8 L bucket with 7.5 – 8 L of DI water and place stir bar inside. 
Next, in a 12000 Da MWCO Dialysis membrane, a mixture of 22 mL of 2 mM 
HAuCl4 (first in the bag) and 5 mL of 3 mM Na2S2O3 (second after the gold 
solution had been added), and let the sample dialyze for 1. The experiment was 
repeated, except a mixture of 44 mL of 2 mM HAuCl4 (first in the bag) and 10 
mL of 3 mM Na2S2O3 (second after the gold solution had been added), and 
sample being dialyzed for 2 hrs (explained in the conclusion of this section). 
Next, spectral scans were obtained after an hour of the self-assembly synthesis at 
room temperature (RT), using a UV/Vis spectrophotometer (Carey 50 Varian). A 
Malvern Zetasizer (ZS90) and TEM (FEI Tecnai F20) were used to characterize 










Sample Peak (nm) Ratio Size (nm) 
Zeta 
(mV) 
22 + 5 (1 hr) 766 1.92 42.1 -35.9 
44 + 10 (1 hr) 988 2.25 42.7 -37.3 
44 + 10 (2 hr) 818 2.38 41 -37.8 
Table 17: nIR spectral peak ,quality ratio, size, and zeta measurements of the scale 
up samples.  













 22 + 5
 44+10 (1 Hr)
 44+10 (2 hr)
 
Figure 39: Normalized spectral profile of the two different scale ups. 
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Using the DiaSynth method, AuNPs has been synthesized at a high purity, as 
mentioned and reported previously. From this experiment, a 12000 Da MWCO 
Dialysis membrane was used to mix 22 mL of 2 mM HAuCl4 with 5 mL of 3 mM 
Na2S2O3, and a mix 44 mL of 2 mM HAuCl4 with 10 mL of 3 mM Na2S2O3. 
Once the dialysis is finished, spectral profile, size, zeta, and TEM measurements 
were taking. For the 44+10 sample, the experiment reported here is the same as 1 hr 
test, on that one 2 hrs was not an option. The 44+11 samples shows little to no 





















Gold nanoparticles (AuNPs) has attracted enormous attention in the field of 
nanotechnology for applications such as, immunoassays, drug delivery, contrast 
enhancement, ex/in-vivo imaging, in-vitro assays, and cancer therapy (theranostic 
applications) (Section 1.2). These nanoparticles have a large surface-to-volume ratio; 
not only does this give a possibility of interaction between the gold nanoparticles and 
biomolecules, but opens the field to various medical applications. Specifically, 
gold/gold sulfide (GGS) nanoparticles have been introduced for many applications in 
addition to gold nanoshells and nanorods, for their smaller size, higher absorptive 
properties, and ease of fabrication. Theranostic applications have emerged as a 
technique to combine diagnosis, treatment, and imaging in cancer research. The ideal 
theranostic approach for cancer therapy has several tunable factors, mostly imaging and 
treatment, with a display of specifically targeting cancer cells.  
In order to use GGS nanoparticles for therapeutic applications, the smaller gold-
colloid contaminants formed during the self-assembly process must be removed. 
Traditionally, colloidal gold particles are removed via multi-step (3X) centrifugation 
(Section 2.2 & 2.4.1), which is not only time consuming but inefficient. The removal of 
colloidal gold will reduce the total number of particles delivered to the body and reduce 
the impact on the reticulo-endothelial system (RES). Once the GGS particles have been 
synthesized, using 2 mM HAuCl4*3H2O and 3 mM Na2S2O3, they undergo a 
multistep centrifugation, Figure 4 shows the spectra of the samples, “as made” and after 
“3X centrifugation”. There is a significant increase in the quality ratio, as seen in Figure 
4, for the “as made” product the RnIR/Au = 0.83; while the particles after multi-step 
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centrifugation has an RnIR/Au = 1.95, as expected the RnIR/Au is increased due to the 
removal of the colloidal nanoparticles.   
The use of Na2S2O3 as an alternative to Na2S has allowed a robust process to be 
developed where the nIR absorbing peak can be precisely controlled. By varying the 
volumes of reactants, this nIR peak can be reproduced time and again with great 
accuracy and precision (+/- 5 nm), in direct contrast with the method used where the 
aging of Na2S had to be within a precise range, and still resulted in particles with nIR 
peaks that could vary as much as +/- 50 nm each time. In addition, the centrifugation 
process selects various components of the population, thus resulting in a shift of the 
peak absorbance wavelength of the final product may be away from the desired peak for 
the application. Detailed analysis of the dialysate and product is performed to 
understand the exact mechanism leading to increased yields, high quality ratio. 
However, this process represents a dramatic shift in production and scale up strategy, 
which could enable wider use of these nIR absorbing particles in a variety of 
applications. 
 
3.2 Temperature Effects 
From basic chemistry, the chemical kinetics deals with reaction rates; and the 
reaction rates is contributed by concentration of reactants, physical state of the reactants, 
temperature at which the reaction takes occurs, and the use of a catalyst.  Under a 
“given” set of conditions, each reaction has its own rate, but can be influenced. For this 
thesis two main influencing factors were used: concentration and temperature. The 
concentration of the sample can affect the frequency of the collisions between reactant 
molecules; in this case it is 2 mM HAuCl4 and 3 mM Na2S2O3.  The temperature can 
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affect the rate by two factors: (1) influencing the frequency and, (2) the energy of the 
reactant collision.  
By adding in these conditions, change in temperature and concentration, prior to 
or during the synthesis of the AuNPs, the equilibrium has shift to favor the formation of 
nIR particles and the quality ratio in several experiments was greater than 1.6. However, 
this ratio was not close to the multi-step centrifugation method. In order to use these 
particles or therapeutic applications it is essential to increase the quality ratio to 2 or 
higher. Other experiments, not reported here, were also done including a modification of 
the two-step method. The two-step method reported by Zhou et al was modified, instead 
of adding in the Na2S2O3 as the secondary addition, the gold solution was added to 
“coat” or for a “shell” on to the GGS particles that are forming. This also resulted in 
RnIR/Au > 1.5, but less than 1.8.   
3.3 DiaSynth 
 
Using dialysis during the production of GGS nanoparticles not only forcing ion-
exchange (by removing reactants or products), but as a consequence the equilibrium of 
the reaction can be shifted to favor the formation of nIR absorbing particles within the 
dialysis tubing and formation of gold colloid outside. Several dialysis MWCO 
membranes were used including: 2KDa, 3.5KDa, 6-8KDa, and 12KDa, samples were 
then reacted for 1 hr in 8 L of DI water at RT. From the spectral profile, given in Figure 
37, dialysis with a 12KDa MWCO dialysis membrane shows the highest quality ratio. 
Next, the experiment was repeated using a 12 MWCO dialysis membrane, varying the 
amount of Na2S2O3 added. As evidenced in Figure 38 & Table 14, using the 2.5 mL of 
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Na2S2O3, further improved the quality ratio. The experiment was repeated using only the 
2.5 mL of Na2S2O3 for statistical analysis.  
  














Figure 41: Spectral profile of GGS nanoparticles synthesized using the ratio 
11+2.5, the experiment was repeated with n = 5. 
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Sample nIR Wavelength Peak (nm) Quality Ratio Size (nm) Zeta (mV) 
11+2.5 
802 1.88 33.72 -35.9 
805 2.00 33.46 -33.8 
785 1.84 32.98 -34.4 
814 1.88 34.23 -34.4 
858 1.81 34.38 -35.3 
Table 18: nIR spectral peak, quality ratio, size, and zeta measurements of sample from 
Figure 41. The average nIR peak is 813 nm ± 27 nm, and the average quality ratio is 
1.88 nm ± 0.07.  
These results indicate the larger pore sizes of the membrane facilitate the 
diffusion and removal of certain species, during the reaction, which favors the 
production of nIR absorbing particles within the membrane.  Additionally, increasing 
HAuCl4/Na2S2O3 ratio shows an increase in purity at a fixed pore size. To allow 
formation of high ratio nIR absorbing nanoparticles compared to gold colloid which are 
a contaminant, in the DiaSynth process samples are dialyzed during the reaction. By 
dialyzing the samples, it allows us to change the kinetics and therefore shifting the 
equilibrium of the reaction. Our assumptions are based on the following system 
equations (2) and (4) shown above. Dialyzing samples at various time points we are 
having ions exchanging, which allows us to control the bandwidth and peak of the 
particles, ultimately help reduce the colloids and remove ions from the solution. This 
effect significantly decreases the gold colloid production, giving us a higher ratio of 
AuNPS nanoparticles compared to colloidal gold. The order to compare the over yield 
of the scale up process, a batch close to the nIR peak with the same volume was made 
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(Table 19). From Table 19, DiaSynth (left side) are GGS particles as made, while the 
right side is the particles as made and with multi-step centrifugation. 
 
DiaSynth  Non-Dialysis 
As made 7.5 OD, 55 mLs 2.5 OD, 55 mLs 
After multistep centrifugation  - 117 OD, .340 mL 
Final Yield  412.5 28.9 
Quality Ratio 2.36 2.38 
       Table 19: Results from the Non-Dialysis and DiaSynth method. 
 The results show that DiaSynth method has a significantly higher final yield ( 7.5 OD x 55 
mL, compared to 117 OD x 0.34 mL) than as made GGS particles after multistep 
centrifugation. In the end, the DiaSynth method as proven to be an effective method on 
synthesizing nIR particles with little to no modification in the GGS synthesis compared to 
as made GGS particles and doing a multi-step centrifugation.  
3.4 Future Direction 
The use of AuNPs in biomedical field has endless applications. Using the DiaSynth 
method, quality of nIR GGS particles has improved tremendously. It is not clear whether 
the particles formed using the DiaSynth method and the RT method are the same “species” 
being formed. Both syntheses allow the formation of the nIR GGS nanoparticles; further 
characterization of the both types of synthesis is required.  
To clarify the reaction mechanism a technique known as x-ray photoelectron 
spectroscopy can be used to understand the oxidization states of the HAuCl4 and Na2S2O3 
and compared to as made product. Other techniques are also recommended such as X-ray 
diffraction patterning to understand the final products of the synthesis; furthermore, for 
detailed characterization Inductively coupled plasma mass spectrometry (ICPMS) 
and  Energy-dispersive X-ray spectroscopy (EDAX).  
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Lastly, further scaling up the DiaSynth is very important, not only from the 
manufacturing perspective but from a medical stand point as well. The GGS particles 
formed must be synthesized for large clinical studies and/or any other application that 
require a large batch of particles. Future scale up models should consider with using an 
automated process and larger volumes. A provisional patent has been filed on the DiaSynth 
process on the unique process, not only is the DiaSynth process more efficient but has a 
higher yield than current processes. Furthermore, this process may be applicable to other 
types of self-assembled one-pot synthesis procedures such as quantum dots if the correct 
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BACKGROUND OF THE INVENTION 
(a)  Field of the Invention 
[0001] Embodiments disclosed herein relate to a method for synthesizing self-
assembling nanoparticles with defined plasmon resonances.  More particularly, certain 
embodiments disclosed herein relate to an improved method for synthesizing self-
assembling gold / gold sulfide nanoparticles by dialyzing samples during the self-assembly 
process. 
(b) Description of the Prior Art 
[0002] U.S. Application Nos. 12/807,792 and 12/807,793, incorporated herein by 
reference in their entireties, disclose gold / gold sulfide (“GGS”) nanoparticles within a 
chitosan matrix, and methods for synthesizing and using the same.  These references 
disclose forming GGS nanoparticles by self-assembly of a sulfide source, such as sodium 
thiosulfate, and a gold source, such as cholorauric acid.  GGS nanoparticles have 
absorbance peaks in the near infra-red (“NIR”) region, which are tunable by varying the 
self-assembly conditions.  During self-assembly of GGS nanoparticles, gold colloid is 
simultaneously formed as a byproduct.        
SUMMARY OF THE INVENTION 
[0003] Embodiments disclosed herein relate to a method for synthesizing self-
assembling nanoparticles.  More particularly, certain embodiments disclosed herein relate to 
an improved method for synthesizing self-assembling GGS nanoparticles by dialyzing 
samples during the self-assembly process.  In some embodiments, an improved method for 
synthesizing GGS nanoparticles disclosed herein provides a higher ratio of GGS 
nanoparticles to gold colloid as compared to the method cited in U.S. Application Nos. 
12/807,792 and 12/807,793.   
[0004] In one embodiment, a method for synthesizing nanoparticles comprises 
blending gold source and a sulfide source within a first chamber, the first chamber being 
separated from a second chamber by a dialysis membrane. 
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[0005] This summary is provided to introduce a selection of the concepts that are 
described in further detail in the detailed description and drawings contained herein.  This 
summary is not intended to identify any primary or essential features of the claimed subject 
matter.  Each embodiment described herein is not intended to address every object 
described herein, and each embodiment does not necessarily include each feature described.  
Other forms, embodiments, objects, advantages, benefits, features, and aspects of the 
present invention will become apparent to one of skill in the art from the detailed 
description and drawings contained herein.   
BRIEF DESCRIPTION OF THE DRAWINGS 
[0006] A better understanding of the present invention will be had upon reference to 
the following description in conjunction with the accompanying drawings, wherein: 
[0007] Fig. 1 is a TEM image of a sample including GGS nanoparticles and gold 
colloid;  
[0008] Fig. 2 is a TEM image of a sample including GGS nanoparticles;  
[0009] Fig. 3 is an image showing the spectra scan of samples from Example 1;  
[0010] Fig. 4 is an image showing the spectra scan of samples from Example 2; 
[0011] Figs. 5A-5B are images showing the spectra scan of samples from Example 
3; 
[0012] Fig. 6 is an image showing the spectra scan of samples from Example 4; 
[0013] Fig. 7 is an image showing the spectra scan of samples from Example 5; 
[0014] Figs. 8A-8C are images showing spectra of samples from Example 6; 
[0015] Fig. 9 is an image showing the spectra scan of samples from Example 7; 
[0016] Fig. 10 is an image showing the spectra scan of samples from Example 8; 
[0017] Figs. 11A-11B are images showing spectra of samples from Example 9; 




[0019] Figs. 13A-B are images showing spectra of samples from Example 11, and 
Figs. 13C-D are charts showing the relationship between peak wavelength and Int ratio 
(defined below), and between quality ratio and Int ratio. 
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT 
[0020] For purposes of promoting an understanding of the principles of the 
invention, reference will now be made to one or more selected embodiments illustrated in 
the drawings and specific language will be used to describe the same.  It will nevertheless 
be understood that no limitation of the scope of the invention is thereby intended; any 
alterations and further modifications of the described or illustrated embodiments, and any 
further applications of the principles of the invention as illustrated herein are contemplated 
as would normally occur to one skilled in the art to which the invention relates.  One 
embodiment of the invention is shown in great detail, although it will be apparent to those 
skilled in the relevant art that some features or some combinations of features may not be 
shown for the sake of clarity. 
[0021] GGS nanoparticles are preferably created by the self-assembly of a sulfide 
source and a gold source.  In some embodiments, the sulfide source is a sulfide salt.  In 
certain embodiments, the sulfide source is sodium thiosulfate (Na2S2O3), sodium sulfide 
(Na2S), or other suitable sulfur-containing chemical or mixture of chemicals.  In some 
embodiments, the gold source is a gold salt.  In some embodiments, the gold source is 
chloroauric acid (HAuCl4), sodium tetrachloroaurate(III) dehydrate (NaAuCl4), or other 
suitable gold-containing chemical or mixture of chemicals.  The absorbance peak of GGS 
nanoparticles can be controlled by cooperatively adjusting the ratio of sodium thiolsulfate 
and chloroauric acid solutions used to create the GGS nanoparticles.  In addition, the 
concentration of each component may also affect the absorbance peak.  Using 
manufacturing methods disclosed herein, stable GGS nanoparticles may be produced with 
absorbance peaks between about 600 nm and about 1000 nm.  In certain embodiments, GGS 
nanoparticles are selectively manufactured to have an absorbance peak substantially 
identical to the wavelength of the laser used to excite the GGS nanoparticles to maximize 
the energy absorbed by the GGS nanoparticles.   
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[0022] Referring now to Fig. 1, gold colloid is a byproduct of GGS nanoparticle 
self-assembly.  Gold colloid has an absorbance peak at 530 +/- 20 nm.  In the methods 
disclosed in the referenced applications, gold colloid is removed through centrifugation. 
GGS nanoparticles are separated from gold colloid by centrifugation.  An example 
separation process is centrifugation at 1000 g for 20 minutes.  Additional centrifugation 
steps may be used to increase purity.   
[0023] Referring now to Fig. 2, GGS nanoparticles are formed in a several shapes, 
including rods, generally triangular plates, and generally spherical bodies.  The term “GGS 
nanoparticles” is not shape specific and includes particles of particular shapes and mixtures 
of shapes.  The shape of individual GGS nanoparticles within a sample affects the overall 
absorbance spectrum of the sample.  Rod-shaped particles, when oriented on end, provide 
an absorbance peak at about 530 nm.  Therefore, even when substantially all gold colloid is 
removed from a sample, a measure of absorbance at about 530 nm may still be present.   
[0024] In some embodiments, a sample contains a gold source and a sulfide source 
which self-assemble into GGS nanoparticles and gold colloid.  The sample is dialyzed 
against deionized (“DI”) water during the self-assembly process.  In certain embodiments, 
the gold source and sulfide source are blended in a bag-shaped dialysis membrane.  In other 
embodiments, the gold source and sulfide source are blended together for a specific length 
of time then transferred into a bag-shaped dialysis membrane.  In certain embodiments, the 
gold source and sulfide source are blended in a first chamber, the first chamber being 
separate from a second chamber by a dialysis membrane.  In certain embodiments, the 
second chamber may be a re-circulating or purged flow water bath.  In certain 
embodiments, the first chamber may be a flow-through dialysis cell.  
[0025] As shown in the examples below, variation in the dialysis time, the 
molecular weight cut off (“MWCO”) of the dialysis membrane, and the ratio of gold source 
to sulfide source modifies the quality ratio of the resulting product and the wavelength of 
the absorbance peak.  Without being bound by theory, it is hypothesized that dialysis 
performed during the self-assembly process forces ion-exchange across the membrane, 
providing a change in reaction kinetics.  This hypothesized change in kinetics results in a 
shift in the equilibrium of the self-assembly reaction which favors GGS nanoparticle 
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production within the dialysis membrane and gold colloid production outside the 
membrane. 
[0026] A “quality ratio” is the ratio of the absorbance of synthesized particles in the 
NIR region (700 nm to 900 nm, for the purposes of this calculation), which corresponds to 
absorbance characteristics of GGS nanoparticles, relative to absorbance at 530 +/- 20 nm, 
which corresponds to the absorbance characteristics of gold colloid.  Earlier GGS synthesis 
methods provided quality ratios in the range of 0.4 – 0.8 prior to any separation steps, such 
as centrifugation.  The method disclosed herein has provided quality ratios above 1.8, above 
2.0, and above 2.3, prior to separation steps, indicating a significantly higher yield of GGS 
nanoparticles. 
[0027] The examples herein disclose the use of dialysis membranes to improve the 
yield of self-assembled GGS nanoparticles.  However, dialysis membranes may be used to 
improve the yield of other self-assembling nanoparticles as well.  In further embodiments, a 
first chemical species and a second chemical species are blended in a first chamber, the first 
chamber being separated from a second chamber by a dialysis membrane, wherein the first 
chemical species and the second chemical species self-assemble into a nanoparticle.  In 
certain embodiments, the first chemical species is a gold source and the second chemical 
species is a sulfide source.  In other embodiments, the first chemical species is a silver 
source and the second chemical species is a nitride source.  In some embodiments, the first 
chamber is a dialysis membrane shaped to form a bag and the second chamber is a liquid-
filled beaker, vial, vat, bucket, or other container in which the first chamber is submerged.  
In other embodiments, a first chemical species may be dialyzed against the second chemical 
species to form self-assembling nanoparticles.  In these embodiments, a first chemical 
species is added into a first chamber and a second chemical species is added into a second 
chamber, the first chamber and second chamber being separated by a dialysis membrane.  
[0028] The following examples are provided to illustrate certain specific features of 
working embodiments and general protocols.  The scope of the present invention is not 
limited to those features exemplified by the following examples.  Spectral scans disclosed in 
the examples were obtained using a UV/Vis spectrophotometer (Carey 50 Varian), and all 
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disclosed wavelengths are in nanometer units.  Nanometer-scale images were obtained 
using a tunneling electron microscope (“TEM”) (200 kV FEI Tecnai F20).    
EXAMPLE 1 
[0029] Fill a 1 L beaker with 800 mL of DI water and include a stir bar. Add a 
mixture of 11 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 in a 3500 Molecular 
Weight Cut Off (“MWCO”) dialysis membrane for 1 hour (sample 1).  For a non-dialysis 
control sample, 11 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 are mixed in a 50 mL 
tube and reacted for 1 hour (sample 2).  Fill a second 1L beaker with 3 mM Na2S2O3.  Add 
25 mL of 2 mM HAuCl4 in a 3500 MWCO dialysis membrane to the second beaker and let 
it react for 1 hour (sample 3).  
[0030] Spectral scans of the samples are shown in Fig 3.  Sample 1 has a peak at 
attributable to gold colloid and a strong, distinct peak in the NIR range attributable to GGS 
nanoparticles.  Sample 2 has a peak attributable to gold colloid and strong absorbance NIR 
range and extending into longer wavelengths.  Sample 3 has a peak absorbance at about 530 
nm and no peak in the 700 – 900 nm range, indicating the formation only of gold colloid.   
EXAMPLE 2 
[0031] Fill a 1 L beaker with 800 mL of DI water and include a stir bar.  Add a 
mixture of 11 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 in a 3500 MWCO dialysis 
membrane to the beaker for 1 hour (sample 1).  For a non-dialysis sample (sample 2), 11 
mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 are mixed in a 50 mL tube and reacted 
for 1 hour.  Separately, fill two 1L beakers with 3 mM Na2S2O3.  To each beaker, add 25 
mL of 2 mM HAuCl4 in a 3500 MWCO dialysis membrane and let them react for 2.5 and 5 
hours, respectively.    
[0032] Spectral scans of the samples are shown in Fig. 4.  As shown, samples 3 and 
4 have negligible GGS nanoparticle formation. 
EXAMPLE 3 
[0033] Fill four 1 L beakers with 800 mL of DI water and stir bar. Place a mixture 
of 11 mL of 2 mM HAuCl4 and 2 mL of 3 mM Na2S2O3 in a 3500 MWCO dialysis 
membrane into two beakers for 1 and 2 hours, respectively (samples 2 and 3 of Fig. 5A).  
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Place a mixture of 11 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 in a 3500 MWCO 
dialysis membrane into two beakers for 1 and 2 hours (samples 2 and 3 of Fig. 5B).  For a 
non-dialysis sample (sample 1 of Figs. 5A and 5B), 11 mL of 2 mM HAuCl4 and 2 or 3 mL 
of 3 mM Na2S2O3 are mixed in a 50 mL tube and reacted for 1 hr.  
[0034] Spectral scans of the samples are shown in Figs. 5A and 5B.  As shown, the 
sample of 11 mL of 2 mM HAuCl4 and 2 mL of 3 mM Na2S2O3 dialyzed in a 3500 MWCO 
dialysis membrane produces the largest peak shift in the NIR range. 
EXAMPLE 4 
[0035] Fill two 1 L beakers with 800 mL of DI water and stir bar. Maintain a water 
temperature of about 100°C.  Add a mixture of 11 mL of 2 mM HAuCl4 and 3 of 3 mM 
Na2S2O3 in a 3500 MWCO dialysis membrane for a 5 minute soak (sample 1).  Add a 
mixture of 11 mL of 2 mM HAuCl4 and 2 mL of 3 mM Na2S2O3 in a 3500 MWCO dialysis 
membrane for a 15 minute soak (sample 2). 
[0036] As shown in Fig. 6, neither sample produced a peak in the NIR range. 
EXAMPLE 5 
[0037] Fill an 8 L bucket with DI water and stir bar. In a 1-step method, a mixture 
of 11 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 in a 3500 MWCO dialysis 
membrane is added for 1 hour (sample 2).  Next for a 2-step method, 4 mL of 2 mM 
HAuCl4 and 3 mL of 3 mM Na2S2O3 are reacted for 30 seconds in a 50 mL tube, then added 
into a 3500 MWCO dialysis membrane with an additional 7 mL of 2 mM HAuCl4 to react 
for an hour (sample 3).  For a non-dialysis sample, 11 mL of 2 mM HAuCl4 and 3 mL of 3 
mM Na2S2O3 are mixed in a 50 mL tube and reacted for 1 hour (sample 1).  
[0038] Spectral scans of the samples are shown in Fig. 7.  As shown, the two step 
method of mixing the gold source and sulfide source shortly before insertion into the 
dialysis membrane resulted in a higher quality ratio, but a lower peak shift, than the one step 
method.   
EXAMPLE 6 
[0039] Fill an 8 L bucket with DI water and stir bar.  Combine samples of 11 mL of 
2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 in 3.5 KDa and 12 KDa MWCO dialysis 
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membranes, and allow each to react for an hour (samples 2 and 3 of Fig. 8A).  For a 2-step 
method, react samples of 4 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 for 30 
seconds, then add 7 mL of 2 mM HAuCl4 and place in 3.5 and 12 KDa MWCO dialysis 
membranes to allow further reaction for an hour (samples 2 and 3 of Fig. 8B).  For a non-
dialysis sample, 11 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 are mixed in a 50 mL 
tube and reacted for 1 hour (sample 1 of Figs. 8A, 8B and 8C).  Additionally, the following 
controls were also synthesized: 2-step, react samples of 4 mL of 2 mM HAuCl4 and 3 mL of 
3 mM Na2S2O3 for 30 seconds, then add 7 mL of 2 mM HAuCl4 and allow to react for 1 
hour (sample 2 of Fig. 8C); 1-step dialysis as above using a 12 KDa MWCO dialysis 
membrane (sample 3 of Fig. 8C); and 2-step dialysis as above using a 12 KDa MWCO 
dialysis membrane (sample 4 of Fig. 8C).   
[0040] Spectral scans of the samples are shown in Figs. 8A – 8C.  In both the 1-step 
process and 2-step process, dialysis provides a greatly increased quality ratio as compared 
to the non-dialysis sample, as shown by the relatively small gold colloid peaks.  For the 1-
step process, Fig. 8A shows that using the 3.5 KDa MWCO dialysis membrane results in a 
greater peak shift and a higher quality ratio than the 12 KDa MWCO dialysis membrane.  In 
contrast, Fig. 8B shows that using a 3500 MWCO dialysis membrane results in the NIR 
absorbance peak shifting to a higher wavelength than the non-dialysis sample for the 2-step 
process.  Fig. 8C shows that the two step process, used without dialysis, does not produce a 
significant fraction of NIR GGS nanoparticles.   
EXAMPLE 7 
[0041] Fill two 1 L beakers with 800 mL of DI water and stir bar.  Maintain a water 
temperature of 65° C in one of the beakers, while the other is left at room temperature (RT).  
Add a mixture of 11 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 in a 3500 MWCO 
dialysis membrane to the RT beaker (sample 2) and the 65° C beaker (sample 3), each for 1 
hour.  For a non-dialysis sample, 11 mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 are 
mixed in a 50 mL tube and reacted for 1 hour (sample 1). 
[0042] Spectral scans of the samples are shown in Fig. 9.  As shown, the yield of 
GGS nanoparticles, as evidenced by the NIR peak, was significantly greater at RT than at 




[0043] Fill an 8 L bucket with DI water and stir bar. Add a mixture of 11 mL of 2 
mM HAuCl4 and 3 mL of 3 mM Na2S2O3 in 2 KDa and 3 KDa MWCO dialysis membranes 
for 1 hour (samples 2 and 3).  For a non-dialysis sample, 11 mL of 2 mM HAuCl4 and 3 mL 
of 3 mM Na2S2O3 are mixed in a 50 mL tube and reacted for 1 hour (sample 1). 
[0044]  Spectral scans of the samples are shown in Fig. 10.  As shown, use of the 
3.5 KDa MWCO dialysis membrane provides a significantly larger NIR peak shifts than the 
2 KDa MWCO membrane.  The following Table 1 is a summary of the absorbance peaks 
and quality ratios for each sample. 
Table 1. Summary of Sample Properties in Example 8 
Samples NIR Absorbance Peak (nm) Quality Ratio 
Sample 1 / No dialysis 928 1.473 
Sample 2 / 2 KDa MWCO 918 1.378 
Sample 3 / 3.5 MWCO 765 1.513 
 
EXAMPLE 9 
[0045] Fill an 8 L bucket with DI water and stir bar. Add mixtures of 11 mL of 2 
mM HAuCl4 and 3 mL of 3 mM Na2S2O3 in three separate 3.5 KDa MWCO dialysis 
membranes for 1, 2, and 4 hour, respectively (samples 2, 3, and 4 of Fig. 11A).  Fill a 
separate 8 L bucket with DI water and stir bar. Add mixtures of 11 mL of 2 mM HAuCl4 
and 3 mL of 3 mM Na2S2O3 in three separate 2 KDa MWCO dialysis membranes for 1, 2, 
and 4 hours, respectively (samples 2, 3, and 4 of Fig. 11B).  For a non-dialysis sample, 11 
mL of 2 mM HAuCl4 and 3 mL of 3 mM Na2S2O3 are mixed in a 50 mL tube and reacted 
for 1 hour (sample 1 of Figs. 11A and 11B).  Spectral scans of the samples are shown in 
Figs. 11A and 11B.   
[0046] The following Table 2 is a summary of the absorbance peaks, extinction 
coefficients, and quality ratios of each sample.  For the non-dialyzed “No Dia” control 
samples, the column “Dialysis Time” simply indicates the delay between mixing the gold 
and sulfide sources and acquiring the spectral data. 
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(sample 1, Figs. 
11A and 11B) 
1 959 0.766 1.179 1.539 
2K Dia 
(sample 2, Fig. 
11B) 
1 899 0.605 0.821 1.357 
2K Dia  
(sample 3, Fig. 
11B) 
2 926 0.632 0.895 1.416 
2K Dia 
(sample 4, Fig. 
11B) 
4 930 0.616 0.889 1.444 
3.5K Dia 
(sample 2, Fig. 
11A) 
1 816 0.599 0.916 1.527 
3.5K Dia 
(sample 3, Fig. 
11A) 
2 815 0.622 1.007 1.620 
3.5K Dia 
(sample 4, Fig. 
11A) 
4 819 0.615 0.967 1.573 
 
EXAMPLE 10 
[0047] Fill an 8 L bucket with DI water and stir bar. Add mixtures of 11 mL of 2 
mM HAuCl4 and 2 mL of 3 mM Na2S2O3 in three separate 3.5 KDa MWCO dialysis 
membranes for 1, 2, and 4 hour, respectively.  Also, add mixtures of 11 mL of 2 mM 
HAuCl4 and 2 mL of 3 mM Na2S2O3 in three separate 2 KDa MWCO dialysis membranes 
for 1, 2, and 4 hours.  For a non-dialysis sample, 11 mL of 2 mM HAuCl4 and 2 mL of 3 
mM Na2S2O3 are mixed in a 50 mL tube and reacted for 1 hour.   
[0048] Spectral scans of the samples are shown in Fig. 12.  As shown, dialysis using 
3.5 KDa MWCO dialysis membranes produced significant peak shifts.  Dialysis using 2 




[0049] Fill an 8 L bucket with DI water and stir bar. Add mixtures of 11 mL of 2 
mM HAuCl4 and 2.5, 3, 3.5, 4, 4.5, or 5 mL of 3 mM Na2S2O3 in 50 mL tubes, or 2 KDa or 
3.5 KDa MWCO dialysis membranes for 1 hour.  The following Table 3 is a summary of 
the samples, their Int ratios, NIR peaks, and quality ratios.  An “Int ratio” is the ratio of the 
volume of gold source to the volume of sulfide source in a given sample, the concentrations 
of the gold source and sulfide source remaining constant between compared samples.  For 
example, 11 mL of 2 mM HAuCl4 and 2.5 mL of 3 mM Na2S2O3 provides an Int ratio of 11 
/ 2.5 = 4.40.  Non-dialyzed samples are identified herein as “RT” or room temperature, 
although all samples were maintained at room temperature throughout the experiment.   
Table 3. Summary of Sample Properties in Example 11 
Dialysis 
Method 
Sample (vol. gold source + 
vol. sulfide source) 
Int Ratio NIR Absorbance 
Peak (nm) 
Quality Ratio 
RT 11+2.5 4.40 none N/A 
RT 11+3 3.67 995 1.675 
RT 11+3.5 3.14 901 1.398 
RT 11+4 2.75 852 1.126 
RT 11+4.5 2.44 807 0.895 
RT 11+5 2.20 779 0.730 
2 KDa 11+2.5 4.40 931 1.588 
2 KDa 11+3 3.67 928 1.421 
2 KDa 11+3.5 3.14 950 1.436 
2 KDa 11+4 2.75 848 1.209 
2 KDa 11+4.5 2.44 771 0.783 
2 KDa 11+5 2.20 771 0.787 
3.5 KDa 11+2.5 4.40 789 1.804 
3.5 KDa 11+3 3.67 816 1.731 
3.5 KDa 11+3.5 3.14 820 1.621 
3.5 KDa 11+4 2.75 834 1.352 
3.5 KDa 11+4.5 2.44 789 1.038 
3.5 KDa 11+5 2.20 747 0.787 
  
[0050] Spectral scans of selected samples from Table 3 are shown in Figs. 13A and 
13B.  More specifically, Fig. 13A includes spectral scans of samples dialyzed in 2 KDa 
MWCO dialysis membranes and Fig. 13B includes spectral scans of samples dialyzed in 3.5 
KDa MWCO dialysis membranes.  Fig. 13C depicts the correlation between NIR peak 
wavelength and Int ratio.  Fig. 13D depicts the correlation between quality ratio and Int 
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ratio.  Note that in several places in Figs. 13C and 13D, a diamond symbol identifying a 
non-dialyzed sample is not visible as it is covered by a square symbol identifying a sample 
dialyzed in a 2 KDa MWCO dialysis membrane.  Fig. 13C indicates that decreasing Int 
ratios generally correlate with NIR absorbance peaks at lower wavelengths.  As shown in 
Fig. 13D, increasing Int ratios generally correlate with increasing quality ratios.   
[0051] The foregoing detailed description is given primarily for clearness of 
understanding and no unnecessary limitations are to be understood therefrom for 
modifications can be made by those skilled in the art upon reading this disclosure and may 
be made without departing from the spirit of the invention.  
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ABSTRACT OF THE DISCLOSURE 
Embodiments disclosed herein relate to a method for synthesizing self-assembling 
nanoparticles with defined plasmon resonances.  More particularly, certain embodiments 
disclosed herein relate to an improved method for synthesizing self-assembling gold / gold 
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I. CONSTITUENCY OF EXAMINATION COMMITTEE 
(Date) 
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II. M.ENG. PROJECT DESCRIPTION 
A brief description of the proposed M.Eng. Project is as follows: 
This project is focused on the scale up of gold-gold sulfide (GGS) nanoparticles with desired near infrared 
peak (nIR) that can be used for therapeutic applications. By combining published the current methods for 1-
step self-assembly and an equilibrium shifting approach, the reaction is shifted to favor the formation of nIR 
absorbing particles.  
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